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Abstract 
 
Biological tubes are ubiquitous structures that carry out vital roles. The formation 
and maintenance of these tubule structures is a fundamental process in most organisms. 
The goal of this work is to get a better understanding of the molecules required for these 
processes. The C. elegans excretory canal provides an ideal model for these studies. The 
family of EXC proteins is required to maintain the tubule shape of the excretory canal. 
Mutations in the exc genes (EXcretory Canal abnormal) result in the formation of fluid-
filled cysts in the lumen of the canal. exc-1 mutants show cysts in the canals that are often 
located at the ends of the canals.  These cysts vary in size and number; from cysts not 
much wider than normal lumen up to cysts expanded to the entire diameter of the worm. 
This dissertation describes the work that I carried out to map, clone, and characterize  
exc-1. 
EXC-1 is homologous to the family of Immunity-Related GTPases (IRGP) and 
contains tandem Ras-homology domains. IRGPs make up a large family of proteins, with 
many of the members involved in the clearance of infectious pathogens, by assisting in 
autophagy. EXC-1 contains highest homology to the member of IRGPs, IRGC, of which 
very little is known. The family of IRGPs, and EXC-1’s homology to this family and the 
Ras superfamily is described here.  
exc-1 is expressed within the excretory canal and the amphid sheath cells, a glial 
structure that ensheaths the amphid neuron sensory endings. exc-1 mutants exhibit 
occasional, abnormal formation of cyst-like structures along the process of the amphid 
sheath, but does not disrupt the formation of the amphid channel, the passageway for 
exposure of amphid dendrites to the outside environment.  
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exc-1 interacts genetically with exc-5 (Faciogenital dysplasia protein 4 
homologue)  and exc-9 (Cysteine Rich Intestinal Protein homologue) in a pathway of exc-
9 ! exc-1 ! exc-5. Binding assays show that EXC-1 and EXC-9 bind when EXC-1 is in 
its wild-type or GTP-bound, active, form.  
This work also describes the studies carried out to identify the subcellular role of 
EXC-1 within the canal. With a group of subcellular markers it has been identified that 
EXC-1 is required for proper trafficking of material from early endosomes to recycling 
endosome within the excretory canal, similar to EXC-5. This work indicates that EXC-1 
and EXC-9 binding is required for downstream activation of EXC-5 for proper trafficking 
within the canal and maintenance of tubule shape.   
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1.1 Focus of Research 
 
Biological tubes are ubiquitous and quite fascinating on both functional and 
structural levels. Most of our major organs are composed primarily of tubes, including the 
millions of nephrons within the kidney and the many intricate tubes of the vasculature 
system, varying extensively in shape and size. Tubes serve as a major transport system 
throughout our bodies, whether it be transporting blood to our toes, or assisting in sending 
a signal to our brain. Regardless of shape and size, all tubes need to properly carry out the 
complex molecular mechanisms required to develop and maintain this structure. Some 
tubes may be transient and short lived, while some tubes function for decades, throughout 
the organism’s entire life. These persevering tubes often require constant remodeling and 
monitoring to remain functional on the structural and subcellular level. 
To get a better understanding of the molecular mechanisms underlying 
development and maintenance of the shape of small biological tubes I have used the 
model organism, Caenorhabditis elegans. The C. elegans excretory canal provides an 
ideal system to examine tube formation and maintenance. Using this genetically tractable 
organism I have mapped, identified, and characterized the gene exc-1; an IRGP 
(Immunity-Related GTPase) homologue required to maintain the narrow lumen within 
this single-celled tube.  
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1.2 Epithelial Structure 
Epithelial structures make up a large part of all biological tissues.  These epithelial 
structures line the outside the body, the inside of the body, and can act as a barrier 
between two regions of the body.  Epithelium can act as protection, such as our skin, or 
the lining of our lungs, both working to constantly fight off many of the world’s 
pathogens and hazards. Epithelial structures also carry out the vital functions that include 
absorption of materials or excretion of chemicals and hormones, including the body’s 
waste.   
Epithelia perform a wide array of functions and adopt different structures and cellular 
arrangements to do this.  An epithelium is often made of many cells that form a sheet-like 
structure.  This sheet is held together and able to communicate through cellular junctions. 
These junctions include: anchoring junctions (ex. desmosomes and hemidesmosomes), 
occluding junctions (ex. tight junctions) and channel-forming junctions (ex. gap 
junctions).   
Epithelial cells are polarized cells, having two (at least) distinct membrane domains 
and asymmetric organization of intracellular organelles and proteins. The apical domain is 
exposed to the external environment, or the lumen of the cavity. This apical surface is 
responsible for distinctive activities depending on cell type, such as excretion from kidney 
cells. The basal domain is attached to a basal lamina, which makes up part of the 
extracellular matrix.  This attachment to the basal lamina and extracellular matrix, allows 
for epithelial cells to communicate with tissues around them, and absorb and secrete 
material into the surrounding area. See Figure 1.2a. 
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Figure 1.2a Simplified diagram of epithelial cells. 
Apical surface indicated in red. Basal and lateral surfaces indicated in blue. A few of the 
many intracellular organelles within a cell are also diagrammed. 
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1.3 Biological Tubes 
Epithelial structures can be found in a sheet-like structure, but also exist as tubular 
structures as well. As with epithelial sheets, it is imperative that biological tubes maintain 
proper apical and basal polarity as well, allowing them to carry out their integral role 
within the organism. Tubes can be found in many different sizes and levels of complexity. 
The diameter of biological tubes can vary from smaller than a micron to many centimeters 
wide. And their complexity can be very simple, such as the esophagus, made of a single 
tube, to the highly complex tubing found within the kidney. Tubes often act to transport 
material from one sight to another, whether it is modifying the material as it passes or 
acting as a passive conduit. To transport material, biological tubes are often born in one 
place and send out processes to their final destination (Lubarsky and Krasnow, 2003).  
  Tubes can be found as multicellular structures, being many cells thick across in 
diameter, or unicellular, composed of an individual cell, Figure 1.3a. The focus of this 
dissertation is on small, unicellular tubes.  No matter the size and complexity of the tube, 
all require basic molecular functions, such as polarization and trafficking of material and 
organelles to specific locations. The apical surface faces towards the lumen, absorbing 
nutrients as they pass through, or secreting materials destined for transportation. The basal 
surface faces the outside of the tube to secrete and take up materials from the surrounding 
areas, Figure 1.3a. 
  Development of tubes occurs in many different ways. Multicellular tubes can 
form by different mechanisms including wrapping, budding, cavitation or cord hollowing, 
Figure 1.3b. Unicellular tubes, however, form by different techniques including cell 
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hollowing, self-fusion and cell fusion, Figure 1.3b (Baer et al., 2009). Cell hollowing 
occurs when vesicles form, coalesce, and fuse to form a lumen that will continue to grow 
and expand. Cell hollowing occurs in the C. elegans excretory canal, the focus of this 
dissertation (Buechner et al., 1999b; Nelson et al., 1983b). Cell fusion occurs when cells 
migrate to meet and only make cellular contacts at the dorsal and lateral regions, allowing 
for a lumen to form between these sites, as seen in the Drosophila heart tube (Santiago-
Martinez et al., 2008). Self-fusion occurs when a cell wraps around and adheres to itself 
via an autocellular junction, a mechanism used by the C. elegans excretory duct (Lubarsky 
and Krasnow, 2003; Schottenfeld-Roames and Ghabrial, 2013; Stone et al., 2009).  
  Once the tube is formed, reaching its desired shape and size, maintenance of this 
structure is required for as long as the organism may need. The molecular mechanisms of 
this maintenance of tubular structure while the organism ages and grows are still relatively 
unknown; and will be the focus of this dissertation.  
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Figure 1.3a Similarities and differences of multicellular and unicellular tubes. 
Apical surface shown in red. Basal and lateral surfaces shown in blue. Image adapted 
from (Buechner, 2002). 
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Figure 1.3b Mechanisms of tube formation. 
(A-D) Multicellular Tubes: (A) Wrapping (B) Branching (C) Cavitation (D) Cord 
hollowing. (E-G) Unicellular Tubes: (E) Cell hollowing (F) Self Fusion (G) Cell Fusion. 
Adapted from (Baer et al., 2009). 
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1.4 Caenorhabditis elegans 
To get a better understanding of biological tubes, specifically small biological 
tubes, the nematode Caenorhabditis elegans serves as a great model. C. elegans has 
served as a model organism for more than 50 years, and was first chosen as a model to 
study the nervous system (Brenner, 1974). C. elegans provides a great model organism for 
studies in genetics, developmental and cell biology for many reasons.  
C. elegans is a free living, soil-dwelling, roundworm that is about 1 millimeter in 
length and can be maintained on agar plates with E. coli as a food source, making them 
relatively cheap to study and maintain. This organism is transparent, allowing scientists to 
see structures within the worm, and through they are relatively simple organisms they do 
contain most of the major tissues and organ systems that are found in more complex 
organisms, Figure 1.4a (Brenner, 1974; Wood, 1988).   
C. elegans are found in two different sexes; self-fertilizing hermaphrodites (XX) 
and males (XO). Within a population, males make up the very small percentage of .5%, 
arising by spontaneous nondisjunction in the hermaphrodite germ line.  A higher 
frequency of males (50%) occurs through mating. Because hermaphrodites are self-
fertilizing, maintenance of homozygous traits is easy, as the progeny of the hermaphrodite 
are genetically identical. The process of introducing mutations or markers into different 
strains is easily done through mating of males to hermaphrodites and plenty of progeny 
are made. Hermaphrodites can produce about 300 progeny through self-fertilization and 
many more if mated (Wood, 1988). 
The life cycle of the worm is relatively fast, about 3 days, if all conditions are 
optimal. There is an embryonic stage, followed by four larval stages (L1-L4) and 
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adulthood, with a cuticle-molting process occurring between each stage (White, 1987). C. 
elegans can enter an alternative developmental stage, called the dauer stage, if they are in 
unfavorable environmental conditions such as overcrowding, or low food supply. While 
entering this dauer stage, the worm closes up its mouth and anus and does not require any 
food, allowing the worm to survive for a longer time. This dauer worm will return to 
normal larval stages if returned to favorable conditions (Cassada and Russell, 1975; 
Riddle and Albert, 1997).  
Another advantage of C. elegans is that their genome is sequenced (Consortium, 
1998) and the cell lineage is known (Sulston and Horvitz, 1977). Hermaphrodites are 
made of 959 somatic cells while the male has 1031 somatic cells, and we know when 
every cell is born and where it will travel to and if it will divide, making it an ideal system 
for studying mutants. 
Because C. elegans has served as a model organism for many years there are very 
useful resources available for investigators. wormbase.org is a source of information about 
the genome and genetics of the worm (Stein et al., 2001). wormbook.org serves as a great 
source of information about research techniques in worms, along with chapters discussing 
different topics, such as cell biology and signal transduction. (Girard et al., 2007). Also 
available is wormatlas.org that supplies many figures and images of C. elegans, which is 
very helpful when attempting to identify cells and structures within C. elegans, especially 
for beginning scientists (D. H. Hall, wormatlas.org). 
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Figure 1.4a C. elegans life stages.  
Images of C. elegans eggs, all the larval stages, and adult stage. Stages are 
distinguishable by size and gonad development. The dauer stage is not pictured here, 
dauer stage occurs between L2 and L3, and are relatively small and narrow. Dauer worms 
also exhibit a ‘clearer’ body phenotype, because they do not require food during this time. 
Adapted from (Fielenbach and Antebi, 2008).  
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1.5 Caenorhabditis elegans excretory canal 
 
The Caenorhabditis elegans excretory canal serves as an excellent model to study 
both tubulogenesis and maintenance of tubule shape, Figure 1.5a. The excretory canal is a 
large single-celled epithelial tube that functions to regulate osmolarity and hydrostatic 
pressure within the worm (Nelson et al., 1983a; Nelson and Riddle, 1984). By being a 
single-celled tube, it removes many of the complexities found in multicellular tubes, such 
as adherens junctions, cell growth and division, which can alter tube structure. The 
excretory canal is part of the excretory system that is composed of the canal cell, gland 
cells and the excretory duct and pore cells, Figure 1.5a. The excretory canal acts as the 
kidney of the worm, taking up fluids and waste from the worm, passing it through the 
canal to the duct cell, and finally excreting out the excretory pore. If the excretory canal is 
laser ablated, the worm will fill up with water pressure and die (Nelson and Riddle, 1984). 
  The excretory canal is born half way through embryogenesis, shortly after 
vesicles start to form and coalesce, coming together to form the lumen of the canal. Once 
the lumen is formed, the canal will send out two processes, one to the left and one to the 
right side of the worm. The right and left canals then transverse the basement membrane 
of the hypodermis and bifurcate to form an anterior and posterior canal, making a large H-
shaped structure. The anterior canals are shorter and narrower relative to the posterior 
canals, 100µm in length by 1µm in diameter and 800-900 µm in length and 2µm in 
diameter, respectively. By the time of hatching, the canal will be approximately half the 
length of the worm. By the end of larval stage 1, the canal will have completely grown, 
terminating near the tail of the worm. As the worm ages, the canal grows passively with 
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the worm, maintaining an open lumen throughout growth and development, Figure 1.5b 
(Buechner et al., 1999a; Nelson et al., 1983a) 
  As the canal grows out, it responds to different extracellular guidance cues. Some 
of the cues are also required for axon guidance, such as netrin and its receptor (UNC-6 
and UNC-5) and the Wnt receptor, Frizzled (LIN-17) (Buechner, 2002).  These molecules 
explain how the tube itself grows out but it does not explain how the lumen grows out.  
  Single-cell tubulogenesis and maintenance of narrow tubule structure depends on 
the interplay of multiple proteins acting in a concerted manner.   Several recent studies 
suggest that the growth of the narrow apical surface of the excretory canal depends on 
osmotic activity to provide turgor pressure to extend the canals (Khan et al., 2013; 
Kolotuev et al., 2013; Schottenfeld-Roames and Ghabrial, 2013).  The excretory canal 
lumen is surrounded by a series of small canalicular vesicles, (Figure 1.5c), containing 
vacuolar ATPase (VHA proteins) and Aquaporin 8 (AQP-8).  During growth or 
hypoosmotic shock, vesicles dock with the apical lumen, where the AQP-8 allows release 
of water to the lumen as well as binding of ERM-1 (Ezrin-Radixin-Moesin homologue) to 
stimulate growth of actin filaments to guide the direction of luminal growth. These studies 
give us an idea of how the excretory canal goes through tubulogenesis, growing out and 
forming its lumenal shape, but much remains to be known about how the excretory canal 
maintains that lumenal shape once it is formed. 
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Figure 1.5a C. elegans excretory canal.  
Apical surface shown as red, basal in blue. Excretory system; composed of the excretory 
canal, two gland cells (not shown), a duct cell and pore cell are indicated. Adapted from 
(Buechner, 2003).  
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Fibure 1.5b Development of the excretory canal.  
(A-D) Display lumen formation and canal growth within the excretory cell. (E-F) Display 
canal growth within the worm, after hatch (at the beginning of L1 – (E)) to adulthood (F), 
step by step process described in reading. Adapted from (Buechner, 2003). 
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Figure 1.5c Cross section of excretory canal. 
(A) A schematic of a cross section of the excretory canal to represent the canaliculi and 
central lumen (B) an electron micrograph of the excretory canal showing the canaliculi 
that extend into the cytoplasm, adapted from (Buechner et al., 1999).  
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1.6 exc mutants 
To get a better understanding of how the excretory canal maintains its narrow 
lumenal structure we study a group of mutants, the EXcretory Canal abnormal (exc) 
mutants. In the exc mutants the worm seems to form the canal normally initially, but loses 
the ability to regulate luminal diameter, resulting in fluid filled cysts. There are nine genes 
within the exc group (exc-1 – exc-9). Cloned genes encode proteins that anchor the 
terminal web to the apical membrane, regulate osmotic pressure and bind to mRNA 
(discussed more in chapter 5). Also, in the past few years; identification of a set of EXC 
proteins that regulate intracellular trafficking within the canal has come together, exc-1, 5, 
and 9.  The main focus of this dissertation will discuss the work that I have carried out on 
mapping, cloning and characterizing the gene exc-1, which encodes a GTPase homolog 
belonging to the family of Immunity-Related GTPase proteins (IRGP). Below shows a 
model displaying what was known about the family of exc’s at the beginning of my 
studies, Figure 1.6. At the end of this manuscript a model including how my work has 
contributed to understanding the mechanism of maintenance in tubule shapes is given.  
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Figure 1.6 Model of the canal at the beginning of my studies.  
exc-4 was identified to encode a Chloride channel, to regulate ion concentrations in the 
canal (Berry et al., 2003) . Cytoskeletal genes encoded by sma-1, and erm-1 are involved 
in actin binding, which were identified by other labs (Gobel et al., 2004; Praitis et al., 
2005). exc-7 encodes a mRNA binding protein that binds to sma-1 mRNA (Fujita et al., 
2003). exc-5, the FGD4 homologue, regulates membrane trafficking with the possible 
help from genetically upstream gene, exc-9. exc-1, 2, 3 and 6 remained to be identified.  
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2.1 Abstract 
  
 To get a better understanding of the genetic and molecular mechanisms required 
to maintain a tubule shape, the Buechner lab studies a group of exc (EXcretory Canal 
abnormal) mutants, exc-1 – exc-9. Some of these mutants have been mapped and cloned, 
and some remain to be identified. This chapter discusses the process of characterizing the 
cystic phenotype, and the mapping and cloning of exc-1. 
 
 
2.2 Introduction 
 
  exc mutants vary in severity of cystic phenotype. Some have lumens just wider 
than wild-type and some mutants have cysts that expand to the entire diameter of the 
worm, Figure 2.2a. exc-1 is unique in that it exhibits varied phenotypes that ranges from a 
very mild phenotype, almost looking wild-type, to a severe cystic phenotype, often 
associated with very short canals. This section describes the characterization of exc-1, in 
! %$!
regard to both cyst size and number, along with canal length. By having an understanding 
of the phenotype of exc-1, I was able to use this information to carry out mapping studies.  
There are many different techniques and methods that can be used for mapping a 
gene (Fay, 2006).  Nowadays, for financial and timing reasons, it is common to sequence 
the entire genome of the organism in question and look for the mutation; unfortunately 
this is not the technique that was not feasible at the time exc-1. exc-1 was mapped by more 
of a ‘classical mapping’ approach. Prior to my joining the lab, exc-1 had been narrowed to 
a region of 282kb located on the right end of the X chromosome by 3-factor and 
deficiency mapping (Buechner et al., 1999a).  exc-1 was predicted to be between the genes 
jud-4 and dyn-1, X:15284208-15568916, a region that contained 31 predicted genes. 
Proceeding with mapping of exc-1, I used a variety of techniques, including deficiency 
mapping, and attempts to rescue the exc-1 cystic phenotype with cosmids, yeast artificial 
chromosomes (YAC’s) or fosmids. RNAi techniques were used as well, to knockdown 
genes within this region in hopes to identify a phenotype similar to exc-1. In the beginning 
of my studies only one allele of exc-1 existed, rh26, which is the allele I used to carry out 
all of my studies and characterizations. Throughout the years other alleles have been 
found, which is discussed in this section. 
I was able to successfully map and clone exc-1 to the predicted gene C46E1.3; 
from there I carried out sequencing and cDNA analysis of this gene, which is described 
here as well.  
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Figure 2.2a exc mutants 
Wild-type canal and exc mutant canals displaying various cystic phenotypes, adapted from 
Buechner et al., 1999. Lumen of the canal is outlined in red, and arrowheads indicate 
canal regions of normal width. Scale bar, 10µm. 
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2.3 exc-1 phenotype 
 
 exc-1 (rh26) is a recessive trait that is 100% penetrant; all worms carrying two 
defective alleles will display a cystic phenotype.  The severity of cystic phenotype can 
vary, from cysts not much wider than a normal lumen, to cysts that expand to the entire 
diameter of the worm (Figure 2.3a).  One consistent phenotype of exc-1 is the presence of 
a cyst located at the end of every posterior canal, whether it is the only cyst or one of 
many (Figure 2.3a). This invariable phenotype of having a cyst located at the end of the 
canal is found in exc-5 (rh232) mutants as well.  
  To characterize this cystic phenotype of exc-1 worms I carried out measurements 
of severity (according to size) and number of cysts, along with canal length. The scale for 
measuring these standards was first described by former graduate student, Xiangyan Tong 
(Tong and Buechner, 2008).   exc-1 worms occasionally display canals extending the full 
length of the worm (7%). However, most exc-1 canals end earlier, Figure 2.3b.  Cysts 
found within exc-1 worms are often small, 84% of the time, with only 3% of the cysts 
observed being large, Figure 2.3c. Mutant worms often exhibit many small cysts located 
throughout the canal. When characterizing the number of cysts per canal, 66% of them 
showed between one and five cysts per canal, Figure 2.3d. Other than the cystic 
phenotype, there is no other obvious phenotype in exc-1 worms; they mate with no 
problems and produce the same amount of progeny as wild-type.  
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      Figure 2.3a exc-1 phenotypes. (A-C) Canal marked by stable cytoplasmic Pvha-1::gfp 
construct in wild-type animal (B), and in exc-1(rh26) animals showing variable effects 
with mild (C) or severe (D) effects on tube diameter and length.  Wide arrows, excretory 
cell body; arrowheads, position of vulva at center of animal; narrow arrows, large fluid-
filled cysts.  Bars, 100 mm. 
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B 
Figure 2.3b exc-1 canal length.  
Measurements carried out as described in materials and methods. (A) shows graphical 
representation of data collected, n=100. BK36 strain contains the cytoplasmic canal 
marker GFP under the control of vha-1 promoter. (B) is a schematic of the scale used for 
determining canal length.  
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B 
Figure 2.3c exc-1 cyst size.  
Determination of small, medium and large cysts was carried out as described in material 
and methods. (A) graphical representation of data collected, n=100. (B) a schematic of 
different sized cysts that was used as a guidance for cyst measurement. 
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Figure 2.3d Number or cysts per canal in exc-1 mutant worms, n=100.  
 
 
 
 
 
 
 
 
 
 
 
! %+!
2.4 Mapping of exc-1  
My initial attempt to map exc-1 was with use of cosmids and Yeast Artificial 
Chromosomes (YAC) spanning the region where exc-1 was predicted to be located. Both 
cosmids and YACs are designed to carry large amounts of DNA, Table 2.4a. After 
preparation and isolation of these constructs, I found that many were not completely intact 
and missing large pieces of DNA, making it difficult to use for experiments. Though attempts 
were carried out to rescue the exc-1 phenotype, by injection of these incomplete cosmids and 
YACs, nothing showed signs of possible rescue and I decided to take another approach. I 
started using fosmids for rescue assays and RNAi techniques.  
The region that exc-1 was predicted to be located in contained 31 predicted genes that 
were covered by 11 fosmids, Figure 2.4a and table 2.4b. Fosmids are a cosmid vector, based 
on the E. coli F factor replicon. By containing the F factor replicon, the copy number is 
limited within a host, resulting in a lower chance of recombination events that may result in 
loss of material.  Fosmids can hold large amounts of DNA, up to 40kb in size, containing 
roughly 4-7 genes (Kim et al., 1992).  By using fosmids I was able to inject large pieces of 
DNA into mutant worms and look for rescue, lowering the number of injections to be carried 
out. If rescue occurred with a fosmid, I would be able to narrow down exc-1 to a specific gene 
located on that fosmid. There were many complications that arose while working with these 
fosmids; these complications are discussed at the end of this chapter.  
Combinations of fosmid injections, and RNAi techniques to knockdown genes in attempt 
to phenocopy the exc-1 mutation were carried out.  RNAi is a technique that knocks down 
gene expression by post-transcriptional silencing (Fire et al., 1998). dsRNA can be 
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administered to C. elegans to induce knockdown of a specific gene by injection (Fire et al., 
1998), soaking (Tabara et al., 1998) or feeding (Timmons and Fire, 1998). 
Eventually, through injection of dsRNA, knockdown of one of the last genes to be tested 
showed a cystic phenotype, similar to exc-1. The corresponding gene was the predicted gene, 
C46E1.3, Figure 2.4h. None of the other genes in this region caused a cystic phenotype when 
knocked down, Table 2.4c. 
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Table 2.4a Cosmids and YAC’s in the region predicted to contain exc-1. 
Cosmid/YAC Region 
CO2D4 X:15273419..15309467 
Y15E3A (YAC) X:15298090..15358349 
C33A11 X:15351371..15376630 
F39D8  
X:15397135..15429293 
R03A10 X:15419538..15470684 
C46E1  
X:15465591..15481691 
H13N06 X:15474951..15511937 
H30A04 X:15510077..15534574 
C02C6 X:15534475..15577853 
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Figure 2.4a Region predicted to contain exc-1.  
Fosmid indicated by different colors and to scale, the fosmid number is indicated. Listed 
below each fosmid are the genes located on the corresponding fosmid. 
 
   
Fosmid Genetic location 
WRM0636cA10 X:15453473..15491654 
WRM066aB08 X:15477056..15522980 
WRM0636aF09 X:15431197..15472039 
WRM0625cF10 X:15340030..15383610 
WRM064cE07 X:15505066..15546925 
WRM0628cC12 X:15301084..15341754 
WRM617dH07 X:15258153..15303833 
WRM066cC10 X:15369963..15418078 
WRM067aA11 X:15411477..15441218 
WRM0618bB07 X:1529034..15323445 
WRM630dB11 X:15536102..15570596 
Table 2.4b Fosmids, including their genetic location, that were used for rescue assays. 
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Figure 2.4h. Young adult, F1 progeny from an injected worm.  
N2 animal injected with dsRNA corresponding to the 6th exon of C46E1.3 and pCV01 
50ng/µl. Knockdown phenocopies the exc-1 (rh26) canal, with a wild-type looking canal 
ending with a small (A) or large (B) cysts, or many cysts (C). Scale bar, 10µm. 
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Table 2.4c.  dsRNAs tested for ability to phenocopy exc-1 mutants   
 
dsRNA 
to clone:  
Predicted Gene 
(from wormbase.org) 
 
Forward Primer 
 
Reverse Primer 
# Animals 
Injected 
 
Result 
ser-2 SERotonin/octopamine 
receptor family  
TGCATACGAATTTGG GAGTTACCGTATGCC 38 No canal cysts 
nhr-91 Nuclear Hormone 
Receptor Family 
GGACTGCCTAGACCG TGAGATCTCGTCAGT 60 No canal cysts 
glb-28 GLoBin Related CTTAAAGTTCGCGTG ATCTTGGAATCGAAT 35 No canal cysts 
Y15E3A.3 None ATATCAGGAAATGAG ATTCATATTAGAAAA 44 No canal cysts 
Y15E3A.4 None AGCACCCACAAATGT CAGAACTGGATACGA 45 No canal cysts 
Y15E3A.5 None CGAGTACCTCTTGAC GCTCTTCAGATCAAT 43 No canal cysts 
C33A11.1 None TGGAAGAACGTGCTT AATGCTTCTTTGCAA 55 No canal cysts 
C33A11.2 None CTACACTATCGCAGT TTTGCCACAAAGAAC 59 No canal cysts 
tag-97 Temporary Assigned 
Gene name 
ACGCGGGGTTTAACC TCCTTGGGATTACAA 27 No canal cysts 
psa-3 Phasmid Socket Absent TCAGCAACACTACGC TACTTGTTTTAAGAA 22 No canal cysts 
pqn-36 Prion-like-(Q/N-rich)- 
domain-bearing protein 
TTTTGGTTCTGGTTT CTGGCTATCAAACTG 25 No canal cysts 
F3D98.3 None GACGAACAGTATTTT CTATTAATTTCTGTC 61 No canal cysts 
nas-13 Nematode AStacin 
protease 
CAATTCTCCCAACTA CAGTCCACTTTTTGG 27 No canal cysts 
RO3A10.1 None TTAATTATTCGGCGG ATTTCAGATTGGATA 23 No canal cysts 
flp-32 FMRF-Like Peptide CCAATATTCCAGCCC ACTAGCAAATTCAGA 25 No canal cysts 
mocs-1 MOlybdenum Cofactor 
Sulfurase  
CATTTCTGACGTGAT AGGAATATCTTCCAT 28 No canal cysts 
nkat-3 Nematode Kynurenine 
AminoTransferase  
CATCGAGCCAGCCTA CACACCCTGTTCTTA 34 No canal cysts 
RO3A10.5 None AGTGCGGAAAAACCG GCTTTACTAATTCCA 48 No canal cysts 
sprr-1 Sex Peptide Receptor 
(Drosophila) Related 
CTATGAAGCTTTGCT CTGCCGCTGTCGCGC 42 No canal cysts 
C46E1.1 None GATTGCTCAACACAA TATATCTAGTGTCAC 57 No canal cysts 
gcy-36 Guanylyl CYclase AAACCTATATGAAGA TTCATTTCCACGTCC 26 No canal cysts 
C46E1.3 None TTTCTTTTCGAAGCC AAAGCGACGAGGACC 63 Canal, glial 
cysts 
H13NO6.2 None AACTGAAAACCATCG AGCGAACTCCAGTCC 41 No canal cysts 
gob-1 Gut OBstructed or 
defective  
CTCTTCACCCGAGCA TTTGAACTCCTAGGG 30 No canal cysts 
suox-1 SUlfite OXidase GAACACAGTTCCATC TACTGCTTTCGCAAT 40 No canal cysts 
tbh-1 Tyramine Beta 
Hydroxylase 
TTGCCCATGCAGCAA CCAGCCGCTCTCGAG 25 No canal cysts 
H13NO6.7 None ATCAAACTGCGCTGC TGCATATTCACATT 43 No canal cysts 
hke-4.2 Histidine-rich 
membrane protein KE4 
(mouse) homolog 
CGCTCATGTCATGA\G CCTTAATGATCCAAG 56 No canal cysts 
eat-20 EATing: abnormal 
pharyngeal pumping 
AGACGAAGATATGAC TTCCGTACTCGTTTC 67 No canal cysts 
olrn-1 Olfactory LeaRNing 
defective 
AATCCCCCAAACTCG GTTGATGGTTTGAGC 30 No canal cysts 
lron-1 eLRR (extracellular 
Leucine-Rich Repeat) 
ONly 
TGTAATTAGCCGAGA ACTAATTTGCGCTGG 15 No canal cysts 
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2.5 Rescue of exc-1 with C46E1.3 
 To determine if predicted gene, C46E1.3, truly was exc-1, attempts to rescue the 
cystic phenotype by injections of corresponding gene were carried out. The predicted 
transcript, as per wormbase, is 6608 bp in length, with the gene gcy-36 being roughly 
1.6kb upstream of C46E1.3. A PCR fragment containing this region of 1.6kb upstream of 
C46E1.3 and the predicted coding region plus 500bp downstream was amplified. This 
PCR fragment was then placed into a TOPO TA vector (Invitrogen!, plasmid pBK102).  
When injected, at 25ng/µl, this construct was able to rescue the cystic phenotype, and 
even show an overexpression, convoluted canal, phenotype, Table 2.5a and Figure 2.5a.  
 
While injecting the gene C46E1.3 into exc-1 (rh26) worms, I recovered a few 
different phenotypes. Some of the F1 progeny from injected worms showed a rescue back 
to the narrow, wild-type phenotype, and some showed an overexpression phenotype. This 
overexpression phenotype results in a convoluted canal. In a convoluted canal the canal 
seems to polarize normally and have proper formation of the lumen and apical surface, 
but the basal surface is disrupted and does not extend out from the cell body. This type of 
overexpression phenotype occurs when overexpressing EXC-5 or EXC-9, as well (Suzuki 
et al., 2001; Tong and Buechner, 2008). 
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Figure 2.5a. Rescue of cystic phenotype with C46E1.3 
(A-C) Microinjection of amplified fragment of fosmid WRM0636cA10 containing the 
promoter and coding region of C46E1.3 DNA rescues canal phenotype in exc-1(rh26) 
mutant.  Arrowheads indicate width of canal cytoplasm.  (A) Arrow indicates canal cell 
body, with both anterior and posterior canals visible (anterior to left).  (B) Posterior canal 
extends full-length to the tip of the animal (arrow) and is of normal diameter (C) Arrow 
indicates overexpression phenotype, the apical surface is maintained, however, the basal 
surface is unable to extend from the cell body and is located ventrally to the posterior 
bulb of the pharynx, indicated by asterisk.  
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Table 2.5a 
Strain/Constructs 
 
 Canal Lumen Length, Number 
 
Cyst Size, Number p-value 
Genotype Injected 
with 
n No 
growth 
and 
short 
Medium 
(midway 
and 3/4) 
Full-length 
(WT and 
convoluted) 
Large  
Medium 
Small None Lumen 
Length 
Cyst Size 
N2  100 0 0 0 0 0 0   
exc-1 
(rh26) 
 100 29 64 7 48 51 1   
exc-1 
(rh26) 
exc-1 + 
pCV01 
(Pvha-
1::gfp) 
66 0 0 66 0 0 66 1.26x 
10-38* 
3.78x10-46* 
exc-1 
(ok5478) 
 33 13 17 3 22 11 0 0.3897* 0.1328* 
*Compared to exc-1 (rh26) 
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2.6 exc-1 mutation and cDNA analysis 
To determine the type of mutation in the exc-1 gene, rh26 allele, the predicted coding 
regions were amplified from exc-1 (rh26) worms and sequenced. From the sequencing 
results, compared to wild-type sequence from wormbase, there was a single base-pair 
mutation (C ! T) located near the end of the 11th Exon.  This mutation changed the 
coding sequence from an arginine (ARG) to an early stop, Figure 2.6a.   
To determine if the predicted exons, as per wormbase, were correct, I isolated 
EXC-1 cDNA from wild-type worms. By sequencing the cDNA, it was found that exon 2 
of EXC-1 is actually shorter than what was predicted (Figure 2.6a). Many attempts were 
carried out to determine if there were two different isoforms of EXC-1, however I was 
only able to extract this shorter sequence, suggesting that this is the only form of EXC-1 
and that the predicted exons on wormbase are incorrect. Wormbase predicts the length of 
EXC-1 to be 763 amino acids in length and I was only able to extract a form that was 738 
amino acids in length, 25 amino acids shorter (SLRSFIEETPILLGSSEHSGSSSPP, 
genomic region X:15477167..15477093).   
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Figure 2.6a. (A) Structure of the exc-1 coding region and encoded protein.  Major 
domains of the protein are shown in color.  Region in black is predicted on wormbase, 
(bases 58-82 of the predicted cDNA) but not found in the amplified cDNA.  Bracket 
shows area of cDNA used for dsRNA injections.  Mutations of rh26 and ok5478 alleles 
are indicated.   
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2.7 exc-1 acts cell autonomously 
To make sure that this shorter form of cDNA was correct and functional, I tested it for 
rescue of the cystic phenotype of exc-1 mutant worms. To do this, the isolated EXC-1 
cDNA was placed into the vector pCV01, Figure 2.7a. This vector contains the canal 
specific promoter vha-1 with the marker, gfp. When this construct was injected into exc-1 
(rh26) worms it was able to rescue the cystic phenotype, confirming that the sequence of 
cDNA isolated is sufficient for function, Figure 2.7b.  By carrying out this study of using 
a canal specific promoter expressing EXC-1 in the canal, and showing rescue, it was 
determined that EXC-1 acts cell autonomously within the excretory canal.  
 
 
 
Figure 2.7a cDNA rescue construct. 
exc-1 cDNA isolated from N2 worms was ligated N-terminally to GFP in the vector 
pCV01. The remaining backbone of this vector is not shown. 
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Figure 2.7b. Rescue by EXC-1 cDNA. 
Top image shows is a schematic of a worm that has a canal partially grown out 
ending with a convoluted portion of the canal,. Bottom image is a young adult, F1 
progeny of a N2 injected with 25ng/µl of Pvha-1::EXC-1cDNA::GFP. Progeny of 
injected worms also exhibited wild-type length canals and fully convoluted canals  
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2.8 Alleles of exc-1 
Because exc-1 (rh26) is a nonsense mutation so late in the gene it is a possibility that 
rh26 might not be a true null allele. Studies that Dr. Matthew Buechner and I have carried 
out suggest that exc-1 is, in fact, a null allele. If exc-1 is placed over a deletion the severity 
of the cystic phenotype does not get worse, suggesting that rh26 is not a partial loss of 
function. 
At the beginning of my studies rh26 was the only allele of exc-1 available. Other 
alleles have been found by the Gene Knockout Consortium (Flibotte et al., 2010; Moulder 
and Barstead, 1998). One allele, ok5478, has a nonsense mutation located in the 4th exon, 
much earlier than rh26, Figure 2.6a. When carrying out phenotypic analysis of this 
ok5478 allele I found that the severity of cysts was the same as for rh26, Table 2.5a.  
Other alleles identified by the Million Mutation project (Consortium, 2012) were 
ordered from the Caenorhabditis Genetics Center (www.cbs.umn.edu/cgc !) and examined 
for cystic phenotypes, Table 2.8a. All of these alleles contained Missense mutations 
within the exons of exc-1 and when observed, they did not exhibit a cystic phenotype. 
Since this time, 59 new alleles have been identified by this Million Mutation project, 
though they have not been examined for cystic phenotypes.   
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Table 2.8a exc-1 alleles identified by the Knockout consortium or the Million mutation 
project that were examined for cystic canals.  
Strain Allele Mutation  Reference 
VC20424 gk303482 Missense – 
Exon 
544G!E Million 
Mutation 
VC20161 gk303483 Missense – 
Exon 
528R!H Million 
Mutation 
VC20598 gk303484 Missense - 
Exon 
374A!T Million 
Mutation 
VC300068 gk303492 Missense – 
Exon 
212T!A Million 
Mutation 
VC20491 gk303494 Missense – 
Exon 
198P!L Million 
Mutation 
VC2008 gk303495 Missense – 
Exon 
164P!S Million 
Mutation 
RB5001 ok5478 Nonsense 302Y!Stop KO Consortium 
(Flibotte et al., 
2010) 
RB5002 ok5960 Missense – 
Intron 
Unknown KO Consortium 
(Flibotte et al., 
2010) 
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2.9 Summary 
C46E1.3 encodes exc-1 
  This work mapped and identified the exc-1 gene as C46E1.3. When C46E1.3 is 
knocked down by RNAi it phenocopies the cystic phenotype of exc-1. Also, a PCR 
amplified product corresponding to C46E1.3 rescues the exc-1 cystic phenotype. We 
conclude that C46E1.3 is exc-1.  
  
EXC-1 cDNA is shorter than predicted 
  By isolation of EXC-1 cDNA and sequencing, it was found that the 2nd exon is 
shorter than predicted. This shortened cDNA is functional and is able to rescue the exc-1 
cystic phenotype. Also, by expressing this cDNA only within the canal we are able to 
determine that exc-1 works cell autonomously within the canal.  
 
exc-1 alleles 
  Allele rh26 has a single base-pair mutation, within the 11th exon, resulting in an 
early stop. This allele is a predicted null mutation, because when placed over a deletion, 
the severity of phenotype does not get worse. Also, allele ok5478, which has a nonsense 
mutation in the 4th exon shows similar cystic phenotype as rh26.  
  
2.10 Materials and Methods 
Worm strains 
 Throughout this disseration; C. elegans strains were maintained by use of 
standard culture techniques on lawns of Escherichia coli strain BK16 (a streptomycin-
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resistant derivative of strain OP50) grown on nematode growth medium (NGM) plates 
(Sulston and Hodgkin, 1988).  Strains were kept at 20°C, unless otherwise noted, and 
phenotypic analyses were carried out on L4 larvae or young adults.   
 
Characterizing exc-1 
Scoring of canal lengths was on a scale from 0 – 4:  A score of (4) was given if 
the canals had grown out to full length; canals that extended past the vulva but not full-
length were scored as (3); at the vulva (2); canals that ended between the cell body and the 
vulva were scored as (1); and if the canal did not extend past the cell body, the canal was 
scored as (0).  Cyst phenotype was measured by count and size relative to normal canal 
width.  Cysts wider than a normal canal up to 1/4 the diameter of the worm were scored as 
small, cysts larger than ! diameter to " the diameter of the worm were scored as medium.  
Any cysts larger than " the diameter of the worm were scored as large. This scheme of 
cyst and canal measurements was used for all phenotypic studies. 
To determine if C46E.13 and the short isoforms of EXC-1 cDNA were able to 
rescue the exc-1 cystic phenotypes, for both length and cyst severity, results from canal 
measurements were binned and analyzed via a 3"2 Fishers’ Exact Test. A p- value of 
0.0001% or lower was regarded as strong statistical significance of rescue; p- values 
between 0.0001% and 0.01% or less were regarded as partial rescue. Performing statistical 
analysis was carried out with the assistance of Stuart MacDonald and was first described 
in the work by former graduate student, Xiangyan Tong (Tong and Buechner, 2008) .  
This is also the analysis that has been carried out for studies in Chapter 5. 
 
! '(!
Constructs and mRNA Isolation 
 YACs and cosmids were supplied by Sanger Institute, Cambridge, UK and 
fosmids were supplied by Bioscience Lifesciences (Source BioScience Cambridge, UK). 
The cosmid and fosmid DNA or YAC DNA was isolated using a DNA prep protocol 
from bacteria and yeast, respectively. Once purified, the DNA was analyzed, to determine 
if the constructs were intact, via digestion with restriction enzymes and gel 
electrophoresis. 
dsRNA was designed to a 300-400 base pair region that corresponded to an exon 
within each gene. A PCR of the corresponding region was carried out and then transcribed 
into dsRNA with the MEGAscript! T7 kit (Life Technologies, InvitrogenTM Grand Island, 
NY).   
A fragment amplified from fosmid WRM0636cA10 via PCR with primers 
5’CCACGTCAGAAAAGAAATATTCTCGCTCCG3’ and 5’ 
TCACATGTTCATCAAGCGGAAAAGTTCACT3’ contained 1.6 kb upstream through 
0.5 kb downstream of predicted gene C46E1.3.  The amplified region was ligated into 
pCR®-XL-TOPO® vector (Life Technologies, Grand Island, NY) and microinjected at 
25ng/µl into exc-1(rh26) mutants.   
Isolation of the cDNA was carried out by extracting the mRNA from wild-type 
worms with a mRNA magnetic bead isolation kit (New England Biolabs, Ipswich, MN). 
To isolate EXC-1 cDNA, specific primers were used (F: 
5’ATGGGACACAAAACCTCAAAAA 3’ AND R: 5’ 
TCAATGAACTCCGGCTGTATCTAGAT 3’). Once isolated, cDNA was ligated into a 
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TOPO vector (Life Technologies, InvitrogenTM Grand Island, NY) and has been 
maintained it in the lab (plasmid, pBK105). 
 
 
Injections 
Microinjections were carried out by injecting into the distal arm of the worm 
gonad (Mello et al., 1991). Injected worms were allowed to recover and scoring of canal 
phenotypes was carried out on their progeny. This microinjection technique is the way 
every microinjection was carried out throughout this dissertation.  
  Fosmids were injected at various concentrations to try and rescue the exc-1 cystic 
phenotype, starting at 100ng/µl and decreasing to 25ng/µl. All fosmids were co-injected 
with canal cytoplasmic marker pVC01 (Pvha-1::gpfp) that expresses GFP only within the 
canal and head mesodermal cell. 
  EXC-1 cDNA construct, Pvha-1::EXC-1cDNA:GFP was injected at a 
concentration of 25ng/µl.  
 
Sequencing 
Sequencing of C46E1.3 was carried in four regions, designed to include the 
predicted coding sequences: Exons 1 and 2, Exon 3 and 4, Exons 5-8 and Exons 9-12. 
These regions were amplified from exc-1 (rh26) worms with the following primers: 
Region Forward Primer Reverse Primer 
Exon 1-2 AGTTGGCTTAAACTTGTGCTCAGCC CCTCTTGTGAGTACGGACGAACC 
Exon 3-4 GCCGTCTGATCCGCCTAAAGAT TTGGGTAAGACTTGGGCGACG 
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Exon 5-8 GGGTAAACCTTGGGCAAGAGTTGG ACGTTCAAAATCATCCGAACG 
Exon 9-12 CAGGGTGTAGTCCACCTT TTCTGCTCCATTCCCACC 
 
DNA sequencing was carried out by ACGT, inc (Wheeeling, IL) then aligned with wild-
type sequence from wormbase by the program, clustalw 
(www.ebi.ac.uk/Tools/msa/clustalw2/).  
 
Microscopy Imaging 
Live worms were mounted on 2% agarose pads with added 10mM muscimol or 
0.5% 1-phenoxy-2-propanol as an anesthetic, as described previously(Sulston and 
Hodgkin, 1988).  Images were captured with a MagnaFire Camera (Optronics) on a Zeiss 
Axioskop microscope with Nomarski optics.   
 
 
2.11 Complications with mapping 
During my work with fosmid injections it looked like multiple fosmids were able 
to rescue the exc-1 cystic phenotype, at first. In the order that I was doing injections 
(Table 2.11a) it looked like there was some rescue when exc-1 worms were injected with 
fosmid WRM064cE07, Figure 2.11a. This was exciting because the fosmid 
WRM064cE07 contained the gene eat-20, a paralog of the Drosophila Crumbs protein. 
Crumbs functions as an apical determinant in many cell types and has been shown to be 
important for tubulogenesis and tube shape in Drosophila melanogaster (Myat and 
Andrew, 2002) It is also known that Crumbs interacts with #-HEAVY  Spectrin and is 
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important for properly maintaining equal apical and basal membrane distribution (Wodarz 
et al., 1995).  Deletion strains of eat-20 (alleles nc5 and nc6) were obtained to check for a 
cystic phenotype. While observing the eat-20 mutant strains, I did not observe a cystic 
phenotype, indicating eat-20 was most likely not exc-1. 
Continuing with injections, it looked like WRM618bB07 or WRM628cC12, 
might have rescued the exc-1 phenotype, though not at a large percentage, Table 2.11a, 
Figure 2.11b and 2.11c. Because the gene, nhr-91, was located on both of these fosmids 
studies were carried out to investigate this gene further. Also, previous studies had shown 
that nhr-91 was expressed in the canal (Gissendanner et al., 2004), making it an even 
more attractive candidate. RNAi experiments were carried out to knockdown nhr-91. 
Knockdown of nhr-91 seemed to disrupt the excretory canal structure, and in some 
worms there seemed to be small cysts, figure 2.11d and 2.11e. These cysts did not look 
like exc-1, either in number or size, and did not occur very often, so I continued with 
rescue experiments with other fosmids.  
While injecting fosmid WRM677aA11 it looked like it might be rescuing the exc-
1 cystic phenotype, Table 2.11a, Figure 2.11f so studies were carried out to test each 
individual gene located on the fosmid for rescue; pqn36, F39D8.3, nas-13, R03A10.1, flp-
32 and R03A10.3.  When injecting these genes individually, many of the F1 progeny 
from all of the injections looked wild-type, indicating that something was wrong with the 
strain that was used for injections, Table 2.11b. As mentioned previously, exc-1 can have 
a very mild cystic phenotype, almost looking wild-type, however not at the rate observed 
during these injections. These results suggested that there had either been a reversion, and 
the mutation in the DNA causing the exc-1 phenotype was no longer present, or there was 
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possible a suppression mutation that arose (through later sequencing it was identified as a 
reversion).  There is a possibility of contamination with another strain, but as this was the 
only worm strain I was working with at the time, this is unlikely. So, I re-thawed one of 
the initial lines of exc-1 (rh26) and continued with the attempts to rescue with fosmids or 
phenocopy with RNAi.  
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Table 2.11a Fosmids 
Injections of fosmids (with pVC01 as co-injection marker) into exc-1 (rh26) worms. 
Fosmid Genetic location Number of 
worms 
injected 
Canals 
Scored (n) 
Percent 
rescued 
WRM0636cA10 X:15453473..15491654 76 81 0 
WRM066aB08 X:15477056..15522980 92 61 0 
WRM0636aF09 X:15431197..15472039 85 50 0 
WRM0625cF10 X:15340030..15383610 103 62 3 
WRM064cE07 X:15505066..15546925 256 123 13 
WRM0628cC12 X:15301084..15341754 130 132 10 
WRM617dH07 X:15258153..15303833 84 54 11 
WRM066cC10 X:15369963..15418078 125 87 7 
WRM067aA11 X:15411477..15441218 162 75 48 
WRM0618bB07 X:1529034..15323445 142 102 6 
WRM630dB11 X:15536102..15570596 153 92 10 
  
 
 
 
 
 
 
! ($!
 
Figure 2.11a Young adult, F1 progeny from injected worm.  
Injection of fosmid WRM064cE07 100ng/µl and pCV01 50ng/µl into exc-1 (rh26). Scale 
bar, 10µm.  
 
 
 
 
 
 
Figure 2.11b Young adult, F1 progeny from an injected worm. 
Injection of fosmid WRM0618bB07 100ng/µl and pCV01 50ng/µl into exc-1 (rh26). 
Scale bar, 10µm. 
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Figure 2.11c Young adult, F1 progeny from an injected worm.  
Injection of fosmid WRM0628cC12 100ng/µl and pCV01 50ng/µl into exc-1 (rh26) . 
Scale bar 10µm. 
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Figure 2.11d Young adult, F1 progeny from an injected worm. 
Injection mixture of dsRNA corresponding to gene nhr-91 and pCV01 50ng/µl into N2 
worms. Scale bar, 10µm. 
 
 
 
 
Figure 2.11e Young adult, F1 progeny from an injected worm.  
Injection mixture of dsRNA corresponding to gene nhr-91 and pCV01 50ng/µl into N2 
worms. Scale bar, 10µm. 
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Figure 2.11f. Young adult, F1 progeny from an injected worm. Injection of fosmid  
WRM0677aA11 100ng/µl and pCV01 50ng/µl into exc-1 (rh26)  Scale bar 10µm. 
 
 
 
 Table 2.11b. Genes from fosmid WRM0677aA11 injected into exc-1 (rh26) worms.  
Gene Canals 
Scored/Injected 
# Cystic (%) # Rescue (%) 
F39D8.3 23/47 15 (65) 8 (35) 
flp-32 27/38 15(56) 12 (44) 
R03A10.1 25/48 5 (20) 20 (80) 
nas-13 13/26 3 (23) 10 (77) 
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3.1 Abstract 
 
  A transcriptional reporter was used to determine temporal and spatial expression 
patterns of exc-1. exc-1 is expressed within the excretory canal and the glial amphid 
sheath cells, another tubular-like structure that ensheaths 12 neurons, located near the 
head of the worm. exc-1 mutants exhibit occasional small cysts along the processes of the 
amphid sheath cells, but these did not seem to prevent the amphid sheath from properly 
wrapping around the amphid neurons.  
 
3.2 Introduction 
Once regarded as strictly structural support, the function and role of glial cells has 
been overlooked for decades. After discoveries that these neuronal supportive cells are 
involved in signaling as well, they have emerged as essential components to understand 
the complex working of the nervous system (Araque et al., 1999; Haydon, 2001; Kuffler 
and Potter, 1964). And although it is estimated that there are five glial cells for every 
neuron, in humans, research on these intricate cells has been slightly neglected. 
(Oikonomou and Shaham, 2010). One of the biggest challenges in study glia is the vital 
role they play in neuronal survival. In most organisms, glia is necessary for neuronal 
survival, so defects within the corresponding glia may result in no neuron to study. In C. 
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elegans, glial cells are not required for neuronal survival; through they play a role in 
neuronal development and function (Bacaj et al., 2008b; Shaham, 2006). The interaction 
of glial cells and neuronal cells is less complicated in C. elegans as well. In the adult 
hermaphrodite there are 302 neurons and 56 neuronal supportive cells, allowing for a 
simpler model to study glia.  
The bilateral amphids, located within the head of the worm, make up the largest 
sensory organ in C. elegans (Sulston, 1983; Ward et al., 1975).  Each amphid contains 12 
sensory neurons, one sheath cell that ensheaths the neuronal dendrites, and one socket 
cell wrapping around the distal part of these dendrites. Through an opening, formed by 
the sheath and socket cells, most of these neurons are exposed to the outside environment 
Figure 3.2a. These 12 sensory neurons exhibit specific responses to different stimuli, 
playing roles in chemotaxis, mechanosensation, osmotaxis and dauer pheromone 
sensation (Bargmann, 2006). Of the 12 neurons, 8 of them pass through the amphid 
sheath and are exposed to the outside environment. The remaining 4 neuronal dendrites 
terminate within the amphid sheath, in a hand-in-glove fashion, Figure 3.2b. The amphid 
sheath is attached anteriorly with the amphid socket via an adherens junction, forming the 
amphid channel, the only tubular portion of the sheath cell Figure 3.2b. (Perkins et al., 
1986; Ward et al., 1975).  
EXC-1 is expressed within the amphid sheath. exc-1 mutants exhibit occasional 
cysts located along the axon-like process. In this section I describe the studies and results 
of characterizing EXC-1 within the amphid sheath. 
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Figure 3.2a C. elegans amphid sheath. 
A schematic to diagram the location of the amphid sheath and amphid channel. Only the 
right amphid sheath is shown. In the close up section, the amphid sheath cell body, 
process and region contributing to the amphid channel is shown. Only one of the amphid 
neurons is shown for clarity, the neuron cell body is located near the amphid sheath cell 
body and sends its dendrite towards the head, where it will either pass through into the 
amphid channel or remain within the sheath.  
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A          B 
Figure 3.2b Amphid channel 
(A) One of the original diagrams displaying the amphid sheath (sh) and amphid socket 
(so) along with the dendrites of neurons that pass through the channel (ASE, ASG,ASH, 
ASI, ASJ, ASK, ADF and ADL) or stay embedded in the amphid sheath (AWA, AWB, 
AWC, AFD) (Perkins et al., 1986). (B) diagram similar to (A) for clarity reasons, image 
from wormatlas.org. 
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3.3 Expression pattern of EXC-1 
To determine where EXC-1 is expressed, a GFP reporter construct was made. 
This transcriptional vector contained the 1.6 kb region upstream of exc-1. This sequence 
of DNA was chosen because of location of neighboring genes. I cloned this promoter 
region into the vector L3691 (a gift from Andy Fire) and injected it into wild-type worms. 
Animals carrying this extrachromosomal array show expression within the excretory 
canals and in the glial, amphid sheath cells, Figure 3.3a. Expression within the excretory 
canals begins shortly after the cell is born, and persists throughout the lifetime of the 
animal. Expression within the amphid sheath cells was not as strong, but also persisted 
throughout the lifetime of the animal. 
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A 
 
B 
Figure 3.3a exc-1 is expressed in the excretory canal and amphid sheath. 
(A) L2 worm (B) Young Adult. Both carrying the extrachromosomal array Pexc-1::gfp. 
Expression is shown in both the amphid sheath (cell body indicated by arrow) and the 
excretory canal (cell body indicated by closed arrowhead). Scale bar 10µm.  
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3.4 Dye-filling assay 
Because the amphid sheath forms a tube like structure as well, this result of EXC-
1 expression here was very exciting. Other studies have identified genes that are required 
for the tubular structure in both the amphid sheath and excretory canal (Perens and 
Shaham, 2005). Because of some overlap in structure and gene requirement, I wanted to 
determine if there were structural defects within the amphid sheath of exc-1 mutants, 
along with the defects in the canal.  
When living wild-type animals are exposed to fluorescent lipophillic dyes, six of 
the eight pairs of amphid neurons fill with dye, allowing for visualization of these 
neuronal processes and cell bodies via fluorescence microscopy (Hedgecock et al., 1985; 
Perkins et al., 1986).  This lipophillic dye enters through the amphid channel, staining the 
amphid neurons by lateral diffusion in the plasma membrane. This dye does not affect the 
viability, development or basic physiological properties of the neurons. Mutations with 
structural defects within the opening of the amphid channel often reduce or abolish the 
amount of dye filling. A class of mutants that are unable to take up this dye are known as 
dyf (DYe Filling) mutants.  
To determine if the structure of the amphid sheath contributing to the amphid 
channel is maintained, I carried out dye-filling assays. exc-1 mutant worms were able to 
take up the dye, staining the neuronal processes and cell bodies, indicating that the 
amphid channel is remains open, Figure 3.5a.  This result isn’t too surprising, as exc-1 
mutants do not exhibit mutations in response stimuli such as mechanosensation (ASH 
neuron) and dauer formation (ASI, ADF, ASG and ASJ neurons), which are controlled by 
amphid neurons passing through the amphid channel (Bargmann, 2006). 
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3.5 Structure of amphid sheath in exc-1 
Though the opening of the amphid channel is still maintained in exc-1 worms, I 
wanted to get a better look at the amphid sheath structure. With a sheath cell marker, 
P::vap-1::dsRED, (a gift from Shai Shaham) I was able to do this. While observing exc-1 
mutant worms I discovered there are small cysts, or cyst like structures, located within 
the process of the amphid sheath, in 60% of the worms observed, Figure 3.5a. The 
amphid sheath process extends from the cell body, distally, to the amphid channel. 
Though this structure is long and slender like the excretory canal, it does not contain a 
lumen. Though exc-1 does not seem to be disrupting the lumen of the amphid sheath, it 
may still be playing a similar role as in the excretory canal.  
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Figure 3.5a  exc-1 mutation has minor effects on amphid sheath cell structure.   
(A-D) exc-1 mutants are able to take up dye from the outside environment indicating that 
the amphid channel remains open. (A,B) Stained with DiO ( C-D) Stained with DiI. (A 
and C) Wild-type worm (B and D) exc-1 (rh26) worms. (E-H) Amphid sheath with the 
cell specific marker, Pvap-1::dsRED (gift from Shai Shaham) in (E and G) wild-type 
worms show a smooth, axon-like process. However, in (F and H) exc-1 (rh26) worms this 
thin process is disrupted and exhibits cyst-like structures along its length. (G and H) are 
close-ups of E and F to indicated the cyst-like structures. Fluorescence in all panels have 
been brightened to show position of amphids and cysts within. Scale bars, 10µm.  
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3.6 Summary 
EXC-1 is expressed amphid sheath and causes cyst like structures 
 By use of a transcriptional, GFP reporter, EXC-1 shows expression in both tube-
like structures, the excretory canal and the amphid sheath. Though EXC-1 does not seem 
to be required to maintain the tubule structure at the distal region of the amphid sheath, it 
is needed for proper structure of the amphid process. In 60% of exc-1 mutant worms, 
there is a cystic-like phenotype found within the amphid process. Continued studies need 
to be carried out to determine what this cyst-like structure is, possibly a build up of 
material.   
This cystic like phenotype within the amphid sheath is very interesting and is 
something that hasn’t been noticed by the lab of Shai Shaham, a lab that studies the 
structure and function of the amphid sheath. (Max Heiman, personal communication). 
 
3.7 Materials and Methods 
Reporter construct 
 The 1.6kb region predicted region to contain the exc-1 promoter was amplified 
from N2 DNA, with the following primers: 
Forward Primer with BamH1 cut site added Reverse Primer with BamHI cut site added 
5’ 
GCGTCGGATCCTCCTAAAAAATTCA
AGTTGAA 
5’ 
CCGCCGGATCCTCATCAAAAATTTT
ATTATCC 
 
This PCR amplified product was then cut and ligated into the backbone of plasmid L3691, 
This final construct remains in the lab as pBK101. 
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Expression analysis 
 
  Wild-type worms were injected with 75ng/µl of pBK101 and their progeny were 
viewed and imaged via DIC and Fluorescence microscopy. Determination of structures 
with GFP expression were identified with the help of wormatlas.org and the C. elegans t 
images that are available (Sulston and Horvitz, 1977) 
 
Dye-filling assay 
 
 These assays were carried out by methods based on original assays performed 
(Hedgecock et al., 1985; Perkins et al., 1986). Worms were grown on NGM agar plates 
according to common practice, then rinsed off the plates with M9 buffer and moved to an 
eppendorf tube containing .01mg/mL lipophilic dye solution. The worms were then 
allowed to soak in this dye solution by rotation at room temperature, in a light-limiting 
tube, for 1.5hrs. Worms were then rinsed with M9 to remove excess dye and transferred 
to an agar plate for recovery. Worms were then observed under fluorescence microscopy. 
The N2 strain served as a positive control, allowing stain to enter through the amphid 
channel and stain the amphid neurons. dyf-11 (mn392) served as a negative control. dyf-
11 mutants have obstructed amphid channels and are unable to take up dye from the 
outside environment (Bacaj et al., 2008a; Perkins et al., 1986; Starich et al., 1995).  
 
Microscope Imaging 
Live worms were mounted on 2% agarose pads with added 10mM muscimol or 
0.5% 1-phenoxy-2-propanol as an anesthetic, as described previously(Sulston and 
Hodgkin, 1988).  Images were captured with a MagnaFire Camera (Optronics) on a Zeiss 
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Axioskop microscope with Nomarski optics.  Confocal images were taken on an FV1000 
Confocal microscope (Olympus) laser scanning confocal microscope, with lasers set to 
488 nm excitation (GFP) or 543 nm excitation (mCherry).  Images were captured via 
FluoView optics, and analyzed with ImageJ software. 
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4.1 Abstract 
 
  The exc-1 gene encodes a large (738 amino-acid) protein with little 
obvious homology along its entire length. Two regions, however, show homology to the 
IRG (Immunity-Related GTPase) family of GTPases, both genetically and structurally. 
The first Ras homology domain shows closer homology to IRG, seems to be acing like a 
true GTPase domain, which is required to cycle between both GTP and GDP bound 
forms.  
 
 
4.2 Introduction 
  exc-1 encodes a large 738 amino-acid protein. With the use of BLAST (Basic 
Local Alignment Search Tool) analysis, EXC-1 did not show strong homology along its 
entire length; though two regions showed homology to the family of Immunity-Related 
GTPases, Figure 4.2a. These two regions of homology contain putative Ras homology 
domains. EXC-1 also contains a proline-rich region located on its N-terminus. The history 
of IRGPs and their role as a family of GTPases is discussed here. 
  The Ras superfamily of GTPases regulate diverse cellular functions including 
membrane trafficking, cytoskeletal control, cell division, cell signaling and nuclear import 
and export (Macara et al., 1996). GTPases carry out these vital roles by cycling between 
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GTP-bound and GDP bound states. A GTPase is considered in its ‘active state’ when a 
GTP is bound and in its ‘inactive state’ when GDP is bound, at what is known as its G-
domain. GTPases switch between these two forms with the aid of guanine nucleotide-
exchange factors (GEFs) and GTPase-activation proteins (GAPs). GEFs catalyze the 
conversion of ‘inactive’ RAS to its ‘active’ form by removing a GDP from the GTPases, 
allowing GTP to bind. GAPs accelerate the rate of hydrolysis of bound GTP to GDP, 
Figure 4.2b.  Because EXC-1 contains two of these RAS-like G domains, it adds to its 
complexity and possible conformational states within the canal, Figure 4.2c. 
Sequence homology among members of the Ras superfamily tends to be very low. 
However they share strong structural homology at the G domain, a region recognized by 
four to five conserved sequence motifs, G1-G5 (Bourne et al., 1990, 1991). G1 (also 
known as the P loop domain) has a conserved sequence of GX4GKS/T with the main-
chain NH groups and the lysine in contact with the phosphates of the nucleotide. G2 (also 
known as switch I) contains a threonine (T) and is important for guanine base specificity, 
along with G3 domain (DxxG) and G4 domain (N/TKxD). The Asp of DxxG (G3, also 
known as switch II), makes a water-mediated contact with the Mg2+ and is important for 
GTP hydrolysis; in some G proteins the Asp can be replaced with Glu (E). G5 may play a 
role with binding to guanine as well, but is weakly conserved. Both of the EXC-1 Ras 
domains clearly contain the characteristic GTP- and GEF/GAP-binding G1, G2, and G4 
domains, with lower homology to the G3 and G5 guanine-interaction domains. The 
structure of EXC-1’s two Ras homology domains is discussed here with comparisons to 
the canonical Ras and IRGP families. 
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Figure 4.2a BLAST results of EXC-1. 
 
BLAST results indicate three homologus regions along its length; an N-terminus proline-
rich region followed by two Ras homology domains, specifically the IRGP family. 
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Figure 4.2b GTPase cycle 
 
GTPases cycle between its GTP bound form, by the assistance of GEFs, and its GDP  
 
bound form, by the assistance of GAPs. 
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Figure 4.3c EXC-1 contains two Ras homology domains 
GTPases can be found in a GTP or GDP bound state (A). Because EXC-1 contains two 
GTPase domains it adds to its complexity and number of possible states it can be found in 
(B).  
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4.3 IRGPs 
Immunity-Related GTPase Proteins (IRGPs) make up one subgroup of the large 
family of Interferon Inducible GTPases (IIGP) (Martens and Howard, 2006).  Like their 
name suggests, members of this IIGP family were identified and grouped together by their 
shared responsiveness to interferon stimuli (Boehm et al., 1998; Gilly and Wall, 1992; 
Lafuse et al., 1995; Taylor et al., 1996). Since their initial discovery, the family has 
expanded immensely, and can be broken up into four subgroups based on their homology, 
relative size, and different responses to interferons: Mx (Myxovirus resistance), guanylate 
binding protein (GBP), very large inducible GTPases (VLIG) and Immunity-Related 
GTPases (IRGP) (Martens and Howard, 2006). EXC-1 only shows homology to IRGPs. 
Members of the IRGP family were initially identified in mice as important 
components in resistance against different intracellular pathogens, working in a pathogen-
specific manner. In mice, IRGPs have been show to be involved in pathogen clearance of  
Listeria monocytogenes, Toxoplasma gondii, Mycobacterium tuberculosis, Salmonella 
typhimurium and Chlamydia trachomatis  (Al-Zeer et al., 2009; Bernstein-Hanley et al., 
2006; MacMicking et al., 2003; Taylor et al., 2000).  
Members of the IRGP family were identified in a piecemeal fashion and it wasn’t 
until 2005 that they were identified and described as a related group (Bekpen et al., 2005). 
23 IRGPs have been identified in mice, of which 20 are functional, suggesting the IRGPs 
play a pivotal role in immune response in mice (Taylor, 2007).  
IRGPs have also been identified in other organisms and vertebrates, including 
Danio rerio (11 IRGP genes), the pufferfish Tetraodon nigriviridis (2 IRGP genes) and 
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the dog Canis familiaris (8 IRGP genes) and humans. To much surprise, humans only 
encode for two IRGPs. The two IRGP members in humans, IRGC and IRGM, are 
homologous to the mice IRGPs, Irgc and Irgm, respectively.  When first identified, by the 
Eichler group, both IRGC and IRGM were predicted to be nonfunctional in relation to 
interferon response (Bekpen et al., 2005).  
IRGC encodes a full-length protein with a G-domain located in the middle of the 
protein. However, IRGC is not inducible by interferon and, as of yet, has only been shown 
to have high expression in the male testis (Bekpen et al., 2005). Because of IRGC’s 
absence from immunity response, in both mice and humans, it hasn’t been the focus of 
many studies, unfortunately. EXC-1 shows strongest homology to IRGC. 
IRGM encodes a small protein (178 amino acids) that has been severely truncated 
on both N and C terminus, when compared to the mouse homologue, and has a very 
interesting history. IRGM still retains its G domain, but was originally thought to be a 
pseudogene. Later it was found that IRGM is expressed in humans but not under the 
control of interferon stimulus. Interestingly, IRGM is constitutively expressed in many 
tissues but shows high expression levels in the testis, along with its IRGC counterpart 
(Bekpen et al., 2005; Bekpen et al., 2009).  
From studies carried out by the Eichler group, it has been proposed that the IRGM 
gene has undergone a unique ‘death and resurrection’. It is believed that IRGM was 
pseudogenized about 50 million years ago, as a result of Alu insertions, resulting in a non-
functional IRGM. IRGM is non functional in all Old World and New World monkeys but 
is functionally restored in both apes and humans. This function has been restored as a 
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result of an integration of an ERV9 element (endogenous retrovirus), upstream of the 
IRGM locus (Bekpen et al., 2009.  
 
Cellular role of IRGPs 
 IRGM and mice IRGPs have been shown to play a role in antiviral autophagy 
(Huett et al., 2009; Petkova et al., 2012; Singh et al., 2006; Singh et al., 2010; Zhao et al., 
2009). In normal conditions, IRGPs show various membrane localizations within the cell, 
many of them being found at the Golgi or the endoplasmic reticulum. Once a pathogen 
has invaded, these IRGPs relocalize, often requiring it be in its GTP-bound state (Martens 
and Howard, 2006; Papic et al., 2008). Most IRGPs contain a myristoylation sequence for 
insertion into membranes, though some IRGPs lack this signal and still are able to bind 
lipids (MacMicking, 2004; Tiwari et al., 2009; Zhao et al., 2010).  EXC-1 does not 
contain a myristoylation sequence or any identifiable signal for membrane binding.  
 
IRGM binding partners  
IRGM has been shown to play a role in autophagy and is a main target of many 
infecting pathogens to either inhibit or promote this process for its own benefit. Studies 
carried out in the Faure lab found that IRGM interacts with autophagy proteins ATG5, 
ATG10, MapILC3B and SH3GLB1, all involved with autophagosome formation and 
cytoskeletal interactions (Gregoire et al., 2011). Another study was carried out, showing 
that the mouse homolog Irga6 (IIGP) binds to a microtubule interacting protein, hook3, 
and may play a role in intracellular trafficking (Kaiser et al., 2004).  
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 This suggests that the family of IRGPs play a role in lipid membrane binding, 
because of their myristolyation and membranous compartment formation, particularly the 
autophagosomes. Plus, because they have been shown to interact with the microtubules 
through protein interactions they may play a role in intracellular trafficking as well.  
Through genome-wide association studies, IRGM has been shown to be associated 
with Crohn’s Disease and Inflammatory Bowel Syndrome. IRGM is important for 
induction of autophagy and clearance of intracellular bacteria and with a loss of this 
function it is believed that this is what induces inflammation within the GI tract of these 
patients (Parkes et al., 2007; Prescott et al., 2010).  
EXC-1 shows strongest homology to IRGC, not IRGM. As stated, unfortunately 
there is not a lot known about IRGC either in mice or in humans, other than it’s high 
expression level in testis. One thing that is exciting about this information is the structure 
of the male testis. The male testis is largely composed of small tubules, the seminiferous 
tubules. Though it is now known what IRGC might be doing on the cellular level, it could 
be something similar to IRGM, such as membrane binding or endosome formation or 
trafficking within the cell.  
 
4.4 EXC-1 RAS domains 
 
As stated, EXC-1 has two Ras homology domains, with strongest homology to the 
family of IRGPs. Table 4.4a shows the consensus sequence found within IRGP G-
domains, and the homologous regions in the 1st and 2nd RAS-like domains of EXC-1. The 
first Ras homology domain contains higher homology than the 2nd, particularly at the G3 
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motif, which is important for guanine base specificity and GTP hydrolysis. However, both 
seem to contain strong homology to the G1, G2 and G4 domains and less homology to G5 
domains.  
There is only one solved structure of the IRGP family, the mouse IRGP, Irga6 
(also known as IIGP)(Ghosh et al., 2004). Irga6 contains two domains, the G domain and 
a helical domain; EXC-1 only has homology to the G domain. The topology of the Irga6 
G domain is identical to the Ras G domain but contains different loop insertions and 
deletions, and is a six-stranded # sheet surrounded by six $ helices; while the typical G 
domain contains 5 $ helices. Irga6 is also found in a dimer formation, which brings the 
two molecules’ myristoylation sequences together, possibly helping with stabilizing 
membrane localization. This dimerization only occurred when Irga6 was in the presence 
of GTP or the non-hydrolyzable analog of GTP, GppNHp. They also found that that this 
dimer is required for GTP turnover and GTP-dependent oligomerization of Irga6. EXC-1 
lacks this helical domain required to dimer formation, but likely does not need one, as it 
contains two G domains that are already physically linked.  
Because there is low sequence homology across Ras members but high structural 
homology I wanted to determine if the Ras homology domains of EXC-1 were structurally 
similar to solved IRGP structure. To do this I used the program I-TASSER.  I-TASSER is 
an open online server that makes model predictions by the use of protein threading 
sequence comparison of known structures within the Protein Data Base (PDB) (Zhang, 
2008).  
The complete sequence of EXC-1 was run through I-TASSER. The protein 
predicted to have the highest structural similarity in the PDB was the crystal structure 
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Irga6, suggesting that EXC-1 has both sequence and structural similarity to the family of 
IRGPs. When comparing the structure solved for Irga6 to the predicted model of EXC-1 
from I-TASSER there was a RMSD (root-mean-square deviation) of 1.50. RMSD is the 
measurement of the average distance between the atoms of the two proteins. After Irga6, 
the next top hit had a RMSD score of 8.40 suggesting that EXC-1 does not have strong 
structural homology outside of IRGP. See Figure 4.4a for predicted structure of EXC-1.  
To determine how closely related each Ras homology domain of EXC-1 is to the 
G domain found within the structure of IRGP, I ran the sequence for each predicted 
domain alone through I-TASSER. Both RAS-like domains of EXC-1 have high similarity 
to the G domain of Irga6 of structural similarity, as well.  
When merging the structures of the G domain from IIGP and the 1st Ras 
homology domain, they were very similar with many of the motifs aligning very well, 
including G1-G4, though G5 did not seem to line up as well. This misalignment of G5 
motif is not that unusual as this motif shows the least conservation across G domains, 
Figure 4.4b.  
When carrying out the same thing for the 2nd Ras homology domain and merging 
its predicted model with the solved structure of IIGP, they also had a very similar 
structure, and alignment of domains Figure 4.4c, though two regions that seemed to 
extend away with no structural homology to Irga6.  
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Table 4.4a Ras domain sequence homology 
The specific subdomains found in a consensus Ras protein, human IRGC, and the first 
and second Ras homology domains of EXC-1.   
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Figure 4.4a Predicted structure of EXC-1 
A model of the predicted structure of EXC-1 from I-TASSER. EXC-1 contains a N-term 
proline-rich region (red) and two tandem Ras homology domains (1st shown in green and 
2nd in orange).  
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Figure 4.4b 1st Ras homology domain merged with Irga6 (IIGP) G-domain 
Colors of the subdomains are as labeled in table 4.4a; G1 (Pink), G2 (Orange) G3 
(Yellow), G4 (Green) and G5 (Red). All subdomains show close positional alignment, 
with the exception of the G5 motif. Irga6 (IIGP) is indicated in dark blue and 1st Ras 
homology domain indicated in light blue.  
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Figure 4.4b 2nd Ras homology domain merged with Irga6 (IIGP) G domain. 
Colors of the subdomains are as labeled in table 4.4a; G1 (Pink), G2 (Orange) G3 
(Yellow), G4 (Green) and G5 (Red). All subdomains show close positional alignment, 
with the exception of the G5 motif. The 2nd Ras homology domain also contains two 
regions that extend from the G domain that show low structural homology to Irga6. Irga6 
(IIGP) is indicated in dark blue and 1st Ras homology domain indicated in light 
blue/cyan.  
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4.5 Different forms of EXC-1 
  Because EXC-1 is a GTPase and a GTPase typically carry out different functions 
within the cell depending on its GTP/GDP bound state, I wanted to determine if there was 
an effect on the canal depending on the conformation of EXC-1. I carried these studies out 
on the 1st RAS domain, as it has higher sequence homology to IRGP compared to the 2nd 
domain, because of the stronger homology of sequence and structural.  
  There are well known mutations that can lock a GTPase in a specific nucleotide-
bound form. Mutations exist that abolish GTPase activity resulting in a GTPase found 
always in its active state (constitutively active). Mutations that block the interaction of the 
GTPase effectors result in an always inactive state (dominant negative) (Bourne et al., 
1990, 1991). Site-directed mutagenesis was carried out on the 1st RAS-like domain, 
specifically at the G1 motif. The mutation of altering the conserved Ser in the G1 box to 
an Asp (S257N), locks the G domain in a GDP-bound, inactive form. By altering the G1 
box of the two conserved Gly to Val, G250V and G255V,  (GX4GKS to VX4VKS) it 
abolishes the GTPase activity causing to be in a constitutively active form.  
  I was able to make these mutations in the plasmid that contained the genomic 
sequence for exc-1, allowing me to use its native promoter to express these alternate 
forms. When the CA form was injected into exc-1 worms it was able to rescue the cystic 
phenotype. However, it did not result in convoluted canals as occurs with normal exc-1 
overexpression injections. This suggests that exc-1 may be required to have the ability to 
cycle between active and inactive states for proper function. When the DN form was 
injected into exc-1 worms it was unable to rescue the cystic phenotype. Also, when 
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injected into wild-type worms, it induced a exc-1 cystic phenotype. This demonstrates that 
the 1st RAS indeed has biological function.  
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Figure 4.5a EXC-1 CA is able to rescue exc-1 (rh26) 
  Young adult, F1 progeny of injected worm. Injection mixture of 25ng/µl of CA 
form of pBK102 (P::exc-1::exc-1) plus 50ng/µl of pCV01 (P::vha-1;;gfp). Arrow 
indicates tip of posterior canal length, with no cyst present. 
 
                                      
Figure 4.5b EXC-1 DN is unable to rescue exc-1 (rh26) 
  Young adult, F1 progeny of injected worm. Injection mixture of 25ng/µl of DN 
form of pBK102 (P::exc-1::exc-1) plus 50ng/µl of pCV01 (P::vha-1;;gfp). Arrows 
indicate cysts along the canal.  
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4.6 Summary 
  EXC-1 shows both sequence and structural similarity to the G domain within the 
family of IRGPs. There are only two members of IRGPs within humans, one with known 
immunity function and the other of unknown function. IRGPs of known function seem to 
be playing a role in autophagy. It is yet to be determined how EXC-1 and IRGPs may be 
similar at the cellular and functional level, outside of sequence and structural similarity.  
  The first RAS seems to act as a functional G-domain, as it carries out different 
functions depending on its GTP/GDP-bound state.  
 
4.7 Materials and Methods 
 
CA and DN constructs 
 
Constitutively active (G250V, G255V) and dominant-negative (S257N) changes 
to the cloned gene were produced through use of the QuikChange® II XL Site-Directed 
Mutagenesis kit (Agilent Stratagene, Santa Clara, CA).  Injections of these constructs 
were at 25mg/µl, the same concentration that wild-type EXC-1 is able to rescue exc-1 
cystic phenotype.  
 
Structural predictions 
 
Structural predictions were carried out with the program I-TASSER, 
(http://zhanglab.ccmb.med.umich.edu/I-TASSER/) 
Modeling manipulation was carried out with the Molecular Modeling Program, Chimera 
(http://www.cgl.ucsf.edu/chimera/).  
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Merged structures of solved Irga6 (IIGP) Ras domain with predicted EXC-1 1st 
and 2nd Ras homology domain structures were also carried out with Molecular Modeling 
Program, Chimera. Chimera merges models passed on pairwise sequence alignments 
based on Needleman-Wunch (Needleman and Wunsch, 1970) and Smith – Waterman 
algorithms (Meng et al., 2006; Smith and Waterman, 1981). 
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5.1 Abstract 
 
 Cloned exc genes encode proteins that are all required for the maintenance of 
tubule shape within the excretory canal but can even be further divided by their 
subcellular roles. The function of EXC proteins vary by anchoring the terminal web to 
the apical membrane, regulate osmotic pressure of the canal lumen, and regulate 
movement of mRNA and endosomes within the cell. By carrying out genetic interaction 
studies we found that exc-1 works in a pathway with exc-9 and exc-5.  
    
 
 
5.2 Introduction 
 
Some of the genes identified necessary for maintenance of tubule shape within the 
canal include structural proteins, such as sma-1 which encodes an the #H heavy chain of 
spectrin, an actin cross-linking protein that supports the shape of the canal (McKeown et 
al., 1998). The Buechner lab cloned exc-7 which is an mRNA-binding protein that binds 
to sma-1, regulating its expression (Fujita et al., 2003). Loss of exc-7 results in small cysts 
all along the length of the canal. ERM-1 (Ezrin, Radixin, and Moesin homolog), another 
structural, actin-binding protein, was found to be necessary for proper canal shape as well 
(Gobel et al., 2004). exc-2 has been studied by a fellow graduate student within the 
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Buechner lab, Hikmat Al-Hashimi, and whole-genome sequencing suggests that exc-2 
may encode an intermediate filament (though this has not been verified through rescue 
assay as of yet – personal communication). Intermediate filaments are structural proteins 
that act as dimers (Lazarides, 1980), and in fact, it has recently been shown that 
intermediate filament (IF), ifb-1,another IF isoform, is required for canal structure 
(Kolotuev et al., 2013). It will be exciting to verify that exc-2 is an intermediate filament 
and determine its role in the maintenance of the tubule shape. Recently, the Grenwald lab, 
has identified exc-6 and found that it encodes a formin protein. Formins assist in actin 
polymerization, de-polymerization and microtubule stability (Wallar and Alberts, 2003).  
Other genes affecting the structure of the canal, resulting in large cysts, have 
included a Chloride Channel, EXC-4 (Berry et al., 2003) and apically secreted proteins, 
including the mucin protein LET-653 (Jones and Baillie, 1995) 
  Genes exc-5 and exc-9 been studied in the Buechner lab and they seem to be 
playing a role in intracellular trafficking (see chapter 7). Former grad student, Xiangyan 
Tong, cloned EXC-9. exc-9 mutant worms are characterized by variable wide and short 
canals, often found with septations Figure 5.2a. exc-9 encodes a small LIM-domain 
protein that is homologous to the human CRIP, Cysteine Rich Intestinal Protein (Tong and 
Buechner, 2008). exc-9 is expressed in other tissues than the canal, including the tail 
spike, uterine seam cell (UTSE), distal tip cells, intestine, ALM and PLN neurons, and 
nerve ring.  
exc-5 encodes a Rho GTPase GEF (Guanine nucleotide Exchange Factor) that is 
homologous to the human protein FGD4, Facial Genital Dysplasia 4 (Mattingly and 
Buechner, 2011).  exc-5 shares expression pattern with exc-9, being expressed in the 
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canal, but is found in additional locations, including the pharynx, rectal epithelial cells, 
and some head and tail neurons (Suzuki et al., 2001). exc-5 mutants are characterized by 
often having a severe cystic phenotype with cysts located at the end of the canal, similar to 
exc-1, Figure 5.2b.  
To test for genetic interactions with other excs I attempted rescue assays of the 
corresponding exc mutants’ cystic phenotype. To do this the construct pBK102 was 
injected into other exc mutants and observed for rescue of the cystic phenotype. pBK102 
is a TOPO vector containing the genomic region of exc-1 plus 1.6kb upstream and 500 bp 
downstream; this is the same vector that shows rescue and overexpression in exc-1 
mutants (See chapter 2).  
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Figure 5.2a exc-9 mutants can exhibit severe cystic phenotypes 
exc-9 (n2669) loss of function worm, arrow indicates cyst near cell body. Image from 
(Tong and Buechner, 2008). 
 
                  
Figure 5.2b exc-5 (rh232) mutants show cyst along the canal and at end.  
exc-5 (rh2320 loss of function worm with cysts located along the length of the canal.  
Scale bar is 10µm.  
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5.3 exc-1 does not interact with exc-2, 3,4, 6 or exc-7 
  When injecting exc-1 into each individual strain: exc-2, exc-3, exc-4, exc-6, and 
exc-7 there were no signs of rescue or improved cystic phenotype. This could suggest a 
couple different things. It is possible that EXC-1 might be working upstream of these 
genes and no matter how many copies of exc-1 are put into the mutant worm it will not be 
able to rescue the cystic phenotype. The other possibility is that exc-1 and these EXC 
proteins work in different pathways for maintaining the tubule shape within the canal.  
 
5.4 exc-1 interacts genetically with exc-5 and exc-9 
 It was previously shown that exc-5 overexpression prevents cyst formation and 
causes convoluted tubules in exc-9 mutants, while exc-9 overexpression has no effect on 
the large cystic canals of exc-5 mutants (Tong and Buechner, 2008).  We examined 
similar interactions for exc-1 mutants.  exc-5 overexpression prevents cyst formation and 
creates convoluted tubules in exc-1 mutant excretory canals, while exc-1 overexpression 
had no effect on exc-5 mutant cysts Figure 5.4a.  exc-1 overexpression prevented the 
formation of cysts in exc-9 mutants, Figure 5.4b, and caused convoluted canals in these 
animals.  Conversely, exc-9 overexpression had no effect on the formation of cysts or 
length of tubules in exc-1 animals.  We conclude that exc-1 acts downstream of exc-9 but 
upstream of exc-5 to maintain tubule diameter, Figure 5.4c and Table 5.4a. All three work 
together genetically, but show different expression patterns that seem to only overlap in 
the canal, which suggests that other proteins interact with exc-1 within the amphid sheath. 
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Figure 5.4a exc-1 and exc-5 interact genetically 
(A) exc-1 does not rescue exc-5 (rh232) cystic phenotype 
Young adult, F1 progeny from an injected worm. Injection mixture was 25ng/µl 
Pexc-1::exc-1, and 75ng/µl of pCV01, Pvha-1::gfp..  
 
(B) exc-5 rescues exc-1’s cystic phenotype and causes overexpression. 
exc-1, F1 progeny from an injected worm. Inset shows a close up of a convoluted 
canal with GFP expression located near the cell body.  Injection mixture: 25ng/µl 
Pexc-5::exc-5::GFP. Image from Brendan Mattingly. 
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Figure 5.4b exc-1 rescues exc-9’s cystic phenotype 
exc-9 (n2669)  young adult, F1 progeny from an injected worm. Injection mixture was 
25ng/µl Pexc-1::exc-1, and 75ng/µl of pCV01, Pvha-1::GFP. 
 
 
 
 
 
 
Figure 5.4c Proposed pathway 
From genetic analysis EXC-9 works upstream of EXC-1 and EXC-5. Also, EXC-1 works 
upstream of EXC-5. 
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Table 5.4a 
Strain/Constructs 
 
 Canal Lumen Length, Number 
 
Cyst Size, Number p-value 
Genotype Injected 
with 
n Almost 
none (no 
growth and 
short) 
Medium 
(midway 
and 3/4) 
Full-length 
(WT and 
convoluted
) 
Large + 
Medium 
S
m
all 
None Lumen 
Length 
Cyst Size 
exc-5 
(rh232) 
 87! 79 8 0 45 38 4   
exc-5 
(rh232) 
exc-1 + 
pCV01 
(Pvha-
1::gfp) 
57 45 12 0 37 20 0 0.051
79+ 
0.1134+ 
exc-9 
(n2669) 
 66! 0 0 66 0 0 66 1.26x 
10-38* 
3.78x10-
46* 
exc-9 
(n2669) 
exc-1 + 
pCV01 
(Pvha-
1::gfp) 
33 13 17 3 22 11 0 0.389
7* 
0.1328* 
+ Compared to exc-5 (rh232) *Compared to exc-9 (n2669) !Numbers from (Tong and 
Buechner, 2008)  
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5.5 Summary 
 From genetic analysis exc-1 does not interact with exc-2, 3, 4, 6 or 7, at least not 
downstream of them in a genetic pathway. Continued work would have to be carried out 
to determine if EXC-1 worked upstream of any of theses genes.  
 EXC-1, EXC-5 and EXC-9 work together in a genetic pathway, determined by 
work from former graduate students and studies carried out here. The proposed pathway 
of this interaction is exc-9 upstream of both exc-1 and exc-5 and exc-1 upstream of exc-5, 
in a exc-9 ! exc-1 ! exc-5 ! pathway. This work gives us a better understanding of 
how these three proteins may be functioning in the excretory canal and how they are 
carrying out roles together in the same pathway to maintain tubule shape.  
 
5.6 Materials and Methods 
Constructs and Injections  
 Construct containing the coding region for exc-1, the promoter (1.6kb upstream) 
and 500bp downstream placed in the TOPO vector (pBK102) was injected into exc 
mutant strains at a concentration of 25ng/µl with a co-injection marker pCV01 at a 
concentration of 75ng/µl. Injected worms were allowed to recover and their progeny were 
observed to canal phenotype and determination of possible rescue and genetic interaction. 
The canal measurements were carried out the same way as described in Chapter 2 
material and methods.  
 Xiangyan Tong carried out injection of exc-9 into exc-1 or exc-5 worms and 
Brendan Mattingly carried out injection of exc-5 into exc-1 or exc-9.  
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Microscope Imaging 
Live worms were mounted on 2% agarose pads with added 10mM muscimol or 
0.5% 1-phenoxy-2-propanol as an anesthetic, as described previously (Sulston and 
Hodgkin, 1988).  Images were captured with a MagnaFire Camera (Optronics) on a Zeiss 
Axioskop microscope with Nomarski optics.   
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6.1 Abstract 
 
 It has been shown that exc-1, exc-5 and exc-9 interact genetically with exc-9 
upstream of both exc-1 and exc-5, and exc-1 upstream of exc-5 in a predicted pathway of 
exc-9 ! exc-1 ! exc-5. Yeast two-hybrid assays indicate EXC-1 binding to EXC-9, and 
that this binding is dependent on EXC-1’s activity.  
 
6.2 Introduction 
Yeast Two-Hybrids 
Because exc-1, exc-9 and exc-5 have been shown to interact genetically from 
work that I have carried out, along with former graduate students Brendan Mattingly and 
Xiangyan Tong, binding assays were carried out to determine if they interacted directly. 
To do this, I used the yeast two-hybrid system. This is a project that I pioneered in the lab 
and a system that will continue to be used successfully. 
Yeast two-hybrids are often used as a screening method, screening through a 
library of proteins to find binding partners. This was not my intention; I used a candidate 
approach based on what we discovered from our genetic interactions. I used a system 
based on the Dup-LEXA% system (Gyuris et al., 1993). The Dup-LexA% system is a 
LexA based version of the original Gal4-UAS system (Fields and Song, 1989).  In this 
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original yeast two-hybrid system, Fields and Song exploited the use of the yeast 
transcriptional activator protein, Gal4. Gal4 has two different domains; the activation 
domain (AD) and the DNA binding domain (DBD), both required for proper transcription. 
Transcriptional activation only occurs when the DNA-binding domain is bound to its 
corresponding DNA sequence and is in close proximity to the activation domain. The two-
hybrid system involves fusing a protein of interest, “X” to the DBD and a protein of 
interest, “Y” to the AD. If proteins “X” and “Y” are binding partners and an interaction 
occurs, this will tether the DBD to the AD and induce transcription. This Gal4 DBD is 
placed upstream of a reporter gene (such as LacZ) to determine possible interactions.  
Instead of using the transcriptional activator, Gal4, the Dup-LexA% system uses 
the E. coli protein, LexA DNA binding protein and an activation protein, the acid blob 
domain B42. Neither LexA nor B42 are able to induce transcription alone. By bringing 
LexA and B42 together in close proximity, transcription of the reporter gene will occur. 
Another advantage is that using prokaryotic proteins instead of eukaryotic, largely reduces 
the number of false positives.   
The reporter gene for my assays was the LEU2 gene that is required for 
production of amino acid Leucine. The reporter construct of LexA-binding sites upstream 
of the LEU2 gene is integrated into the yeast strain EGY48. This allows for easy 
detection of a protein interaction. When the yeast is grown on plates that lack Leucine 
they will only be able to survive if they activate the LEU2 gene and produce it 
themselves. With the design of this system only yeast with binding interactions will 
produce Leucine when placed on –LEU plates. The general set up of this system is shown 
in Figure 6.2a. 
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To carry out these assays, I designed constructs according to Table 6.2a. The bait 
construct (plasmid pEG202) contains a protein of interest in frame with the LexA DNA-
binding protein along with the HIS3 gene. The presence of the HIS3 gene allows for 
confirmation of proper transformation of the plasmid into the yeast. This also allows for 
indication that protein of interest is produced and is not lethal to the yeast. The prey 
construct (plasmid pJG4-5) contains a protein of interest in frame with the acid blob 
domain B42. This construct also included the TRP1 gene, allowing detection of proper 
transformation and non-lethality.  All of the empty bait and prey constructs were provided 
from Barth Grant at Rutgers University.  
 
Gateway System 
 In this yeast two-hybrid system, I also used another relatively new technique for 
the lab, the Gateway! Cloning technique.  This Gateway! system manipulates the 
recombination properties found in bacteriophage lambda and the integration and excision 
of phage & from E. coli bacterial genome (Nunes-Duby et al., 1989).  It manipulates the 
DNA recombination sequence found within lambda and E. coli (att sites) and the proteins 
that mediate the recombination event, the site-specific recombinase (Int) Excisionase 
(Xis) and E. coli Integration Host Factor (IHF). These proteins bind to the specific att 
sites, bringing these sites together, which then go through cleavage and recombination by 
assistance of the other proteins.  Recombination events will occur at these att sites, which 
are conservative, and result in no loss or gain of nucleotides.  The reactions carried out 
involved the att sites, L and R. The Gateway! system allows for these recombination 
events to occur between vectors containing these sites, the entry vector and destination 
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vector. The entry vector will contain the gene or sequence of interest flanked by attL 
sites. The destination vector will contain attR sites flanking the lethal gene, ccdB. With 
the destination vector containing the ccdB gene, when recombination occurs, the 
sequence of interest will be inserted into the destination vector and the by-product, entry 
vector, now containing the ccdB gene, will be eliminated when grown in normal E. coli 
cells, such as DH5#, see Figure 6.2b.  
  The Gateway! system is great for many reasons. With this system you don’t have 
to deal with the challenges of typical cloning and use of restriction enzymes. You don’t 
have to worry about use of a restriction enzyme that may have a recognition sequence in 
your gene of interest. There is no designing of primers containing cut sites and everything 
remains in frame. You also avoid a lot of the clean up and screening process that occurs 
with typical cloning because of the selectable ccdB gene. And the quality I find most 
important and valuable is the time that is saved by using this system.  
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Figure 6.2a Design of Y2H 
The bait consists of the protein or sequence of interest in-frame with the LexA DNA-
binding domain (BD). The BD binds to the LexA operator site on the DNA, upstream of 
the LEU2 gene that is incorporated in yeast strain, EGY48.  The prey consists of the Blob 
42 activation domain that will interact with RNA polymerase and is in frame the protein 
or sequence of interest. If interaction occurs everything will come together and activate 
transcription the LEU2 gene.  
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Table 6.2. Yeast Two-hybrid studies 
Bait Prey Interaction? 
Empty Vector Empty Vector No 
Empty Vector EXC-1 No 
Empty Vector EXC-5 No 
Empty Vector EXC-9 No 
Empty Vector EXC-1 1st RAS CA No 
Empty Vector EXC-1 1ST RAS DN No 
Empty Vector EEA-1 No 
Empty Vector RME-1 No 
Empty Vector EXC-1 Region 1 No 
Empty Vector EXC-1 Region 2 No 
Empty Vector EXC-1 Region 3 No 
Empty Vector EXC-1 Region 4 No 
EXC-1 Empty Vector No 
EXC-1 EXC-1 No 
EXC-1 EXC-5 No 
EXC-1 EXC-9 Yes 
EXC-1 EXC-1 1st RAS CA No 
EXC-1 EXC-1 1ST RAS DN No 
EXC-1 EEA-1 No* 
EXC-1  RME-1 No 
EXC-1 EXC-1 Region 1 No 
EXC-1 EXC-1 Region 2 No 
EXC-1 EXC-1 Region 3 No 
EXC-1 EXC-1 Region 4 No 
EXC-1 1st RAS CA Empty Vector No 
EXC-1 1st RAS CA EXC-1 No 
EXC-1 1st RAS CA EXC-5 No 
EXC-1 1st RAS CA EXC-9 Yes 
EXC-1 1st RAS CA EXC-1 1st RAS CA No 
EXC-1 1st RAS CA EXC-1 1ST RAS DN No 
EXC-1 1st RAS CA EEA-1 No* 
EXC-1 1st RAS CA RME-1 No* 
EXC-1 1st RAS DN Empty Vector No 
EXC-1 1st RAS DN EXC-1 No 
EXC-1 1st RAS DN EXC-5 No 
EXC-1 1st RAS DN EXC-9 No 
EXC-1 1st RAS DN EXC-1 1st RAS CA No 
EXC-1 1st RAS DN EXC-1 1ST RAS DN No 
EXC-1 1st RAS DN EEA-1 No 
EXC-1 1st RAS DN RME-1 No 
EXC-5 EXC-1 No 
EXC-5 EXC-5 No 
EXC-5 EXC-9 No 
EXC-5 EXC-1 1st RAS CA No 
EXC-5 EEA-1 No* 
EXC-5 RME-1 No* 
EXC-9 Empty Vector No 
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EXC-9 EXC-1 Yes 
EXC-9 EXC-5 No 
EXC-9 EXC-9 No 
EXC-9 EXC-1 1st RAS CA Yes 
EXC-9 EXC-1 1ST RAS DN No 
EXC-9 EEA-1 No* 
EXC-9 RME-1 No* 
EXC-9 EXC-1 Region 1 Yes 
EXC-9 EXC-1 Region 2 Yes 
EXC-9 EXC-1 Region 3 No 
EXC-9 EXC-1 Region 4 No 
EEA-1 Empty Vector No 
EEA-1 EXC-1 No 
EEA-1 EXC-5 No 
EEA-1 EXC-9 No* 
EEA-1 EXC-1 1st RAS CA No 
EEA-1 EXC-1 1ST RAS DN No 
EEA-1 EEA-1 Yes 
EEA-1 RME-1 No 
RME-1 Empty Vector No 
RME-1 EXC-1 No 
RME-1 EXC-5 No 
RME-1 EXC-9 No 
RME-1 EXC-1 1st RAS CA No 
RME-1 EXC-1 1ST RAS DN No 
RME-1 EEA-1 No 
EXC-1 Region 1 Empty Vector No 
EXC-1 Region 1 EXC-1 No 
EXC-1 Region 1 EXC-9 Yes 
EXC-1 Region 2 Empty Vector No 
EXC-1 Region 2 EXC-1 No 
EXC-1 Region 2 EXC-9 Yes 
EXC-1 Region 3 Empty Vector No 
EXC-1 Region 3 EXC-1 No 
EXC-1 Region 3 EXC-9 No 
EXC-1 Region 4 Empty Vector No 
EXC-1 Region 4 EXC-1 No 
EXC-1 Region 4 EXC-9 No 
 
*Indicate combinations that have been tested only once, and may need to be retested for 
confirmation. Remainders were tested on two separate events and transformation 
combinations.  
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Figure 6.2b. Design of Gateway reactions 
The Gateway! system allows for efficient transfer of sequence of interest into desired 
destination vector. Selection of desired construct is achieved by insert of ccdB gene into 
undesired pENTR vector.  Description of process found in the reading. 
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6.3 Results of Yeast-two hybrid studies 
Through the use of the Gateway system, many different constructs were made in 
both the prey and bait vectors, Table 6.2a. To test for interactions, I tested one protein of 
interest, “X” as bait and the other protein of interest, “Y” as the prey. I also carried out the 
reverse test, “Y” as bait and “X” as prey, for most.  
As expected, many of the proteins and combinations were tested did not show an 
interaction, except for EXC-1 and EXC-9 Figure 6.3b. When this combination of EXC-1 
and EXC-9 were carried out in either conformation, (EXC-9 – Bait, EXC-1 Prey and 
EXC-1 – Bait and EXC-9 – Prey) binding occurred and transcription of the reporter gene 
was observed. Because EXC-1 is a GTPase it is thought that it can be found in many 
different forms, active and inactive. And because EXC-1 has two predicted GTPase 
domains it adds to the number of possible forms and complexity. I wanted to determine if 
EXC-1 needed to be in a certain state to interact with EXC-9.  
Most of the studies carried out in regards to active or inactive GTPase domains 
were focused on the 1st Ras-homology domain, for a few reasons. First, this region shows 
higher homology to the family of IRGP’s. The other reason that I focused on the 1st G 
domain was because of many failed attempts to make CA and DN mutations to the second 
G domain. 
When testing for interactions with EXC-9, it was found that EXC-1 was required 
to be in its wild-type state, when it had not been altered, and when EXC-1 was in its CA 
form (G250V and G255V) but not in its DN form (S257N). This suggests that the 1st G 
domain, in fact, is functional and that it does carry out different roles whether it is found 
in its active or inactive state.  
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To determine the location of binding of EXC-1 to EXC-9, I broke up the EXC-1 
protein into regions and tested for interactions with EXC-9. The regions are as follows: 
Region1: ATG (aa1) to before 1st RAS domain (aa228) 
Region2: The 1st RAS domain (aa222-aa355) 
Region 3: Region between the two RAS domains (aa340-aa517) 
Region 4: 2nd RAS to stop codon (aa507-aa738) 
See Figure 6.3a. 
  When these different regions of EXC-1 were tested for interaction with EXC-9 
the region 1 and region 2 showed binding, Figure 6.3b. Region 1 contains the proline rich 
region, and since proline-rich regions have been found to be important for protein binding, 
these results weren’t that surprising (Williamson, 1994). It is interesting that the region 
containing the 1st RAS binds EXC-9. This is interesting because when EXC-1 is in the DN 
form it does not bind to EXC-9. This could mean a few different things. First, EXC-9 
might be binding to a region that spans these two regions tested. The second is that EXC-1 
might undergo a conformational change depending on its conformation that would change 
the binding properties. When looking at the predicted structure of EXC-1 (See Figure 
4.4a) it seems like EXC-1 could very likely undergo a conformational change and possible 
bending between the proline-rich region and the 1st Ras homology domain, which may 
affect its binding when in active or inactive state. More studies would need to be carried 
out to test these possibilities.  
  From work described in Chapter 7, it was found that EXC-1 and EXC-5 seem to 
be playing a role in trafficking within the excretory canal and seem to be working in a 
pathway that disrupts trafficking molecules, EEA-1 and RME-1. Because of this, I also 
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carried out yeast two-hybrids to determine if there was any binding occurring between 
EEA-1 or RME-1 with EXC-1, EXC-5, or EXC-9. Results indicate that there is no direct 
binding occurring between any of these molecules, except for homodimerization between 
EEA-1, which is known to occur within the cell for proper function in trafficking 
(Callaghan et al., 1999),  
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Figure 6.3a Different EXC-1 constructs 
The constructs that were tested for binding interactions with EXC-9 are 
diagramed here, red indicates the proline-rich region, green the 1st Ras homology domain, 
and orange the 2nd Ras homology domain. Star indicates site of mutation to a 
constitutively active form and ‘x’ indicates site of mutation to a dominant-negative form.  
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Figure 6.3b EXC-9 and EXC-1 binding 
EXC-9 does not bind to the empty prey vector, EXC-1 DN, or Region 3 or 4 of EXC-1, 
however, it does bind to EXC-1 in wild-type and CA forms. EXC-9 specifically binds to 
Region 1 (proline-rich) and the Region 2 (the 1st Ras homology domain). 
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6.5 Summary 
Since exc-1 shows genetic interactions with exc-5 and exc-9, we performed yeast 
2-hybrid assays between EXC-1 and these other two proteins.  We expressed wild-type 
exc-1 in yeast plasmids as well as engineered mutants that contained the presumably 
constitutively active G249V, G254V or dominantly negative S257N forms of the first 
Ras-homology domain, as the second Ras-like domain has lower homology to that of 
IRG proteins.  No form of EXC-1 showed hybridization to EXC-5.  In contrast, both the 
wild-type and constitutively active forms of EXC-1 indicated binding to EXC-9.  To 
confirm these results, we are currently testing interactions with a GST-expression assay. 
 We conclude that activated EXC-1 interacts downstream of EXC-9 through 
direct binding to effect trafficking at the early endosome, and these proteins stimulate 
EXC-5 through an indirect mechanism. 
 
6.6 Materials and Methods 
Constructs 
For yeast 2-hybrid studies, various forms of the EXC-1 protein were cloned into 
the pENTR vector (Invitrogen), then moved via Gateway recombination reaction into 
plasmid pEG202 two-bait vector in-frame with the LexA DNA-binding domains, and into 
plasmid pJG4-5 in-frame with the activation protein’s acid blob domain B42 fused to an 
HA tag (OriGene Technologies, Rockville, MD).  
mRNA from N2 animals was isolated via Magnetic mRNA Isolation Kit® (New 
England Biolabs, Ipswich, MA), reverse transcribed to cDNA with Finnzymes’ Phusion® 
! $$)!
RT-PCR Kit (New England Biolabs, Ipswich, MA) and were PCR-amplified with 
primers to various sections of the exc-1 gene.  
(5’ end of the coding region:  5’CACCATGGGACACAAAACCTC3’ and 
5’CTACCCACTTCTTCCACAAAATCC3’;  
1st Ras-like domain: 5’CACCGGATTTTGTGGAAGAAGTGGGT3’ and 
5’CTAGTTTTCTCGGTTTTCTGCGTC3’;  
center: 5’CACCCTCCTAACAAAAAGCGAC3’ and 
5’CTATCTTCCTCCAATAAATCCG;  
2nd Ras-like domain and 3’ end of the coding region: 
5’CACCACATGCTTCAACTACGGA3’ and 
5’TCAATGAACTCCGGCTGTATCTAG3’). 
 
Transformations and Y2H 
 
 All assays began with the yeast strain EGY48 that contains the LEU2 gene 
downstream of the LexA operator site integrated into the genome. Also within this strain 
was the reporter plasmid pSH18-34 that contains 8 operator sites of LexA upstream of 
LacZ and the URA3 coding region. This reporter plasmid indicates strong binding when 
plated on plates containing Galactose and X-gal. (indicated by blue colonies).  
 The bait plasmid was transformed first into this EGY48 strain with the reporter 
plasmid and then grown on –URA-HIS plates for selection of yeast colonies that 
contained the plasmid, which was then used for continued assays.  Then the prey plasmid 
was transformed into this corresponding strain and grown on –URA-HIS-TRP plates for 
selection of yeast colonies that contained all there plasmids. Three colonies were chosen 
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from this transformation for final assays to determine binding interactions.  Each yeast 
strain was streaked onto different plates: Glucose –URA-HIS-TRP served as a positive 
control, Galactose –URA-HIS-TRP plus X-gal was used to determine strong binding 
interactions (indicated by blue colonies). Plates Galactose –URA-HIS-TRP-LEU were 
test plates. Controls were carried out with empty plasmids, which should not show 
growth on the test plates, and did not in these studies.  
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7.1 Abstract 
 With a group of subcellular markers, EXC-1 was found to be required for proper 
trafficking within the excretory canal, specifically trafficking from the early to recycling 
endosomes, indicated by build-up of early endosome marker, EEA-1, and loss of 
recycling endosome marker, RME-1. This disruption of trafficking at this location was 
also found in exc-5 loss of function. This section discusses trafficking within polarized 
epithelial cells and how loss of exc-1 affects trafficking within the excretory canal 
determined with the use of nine subcellular markers.  
  
7.2 Introduction 
  Within a cell, proteins and molecules are constantly being synthesized and 
recycled; many of these are being shuttled between cellular compartments, neighboring 
cells and the surrounding environments through exocytosis and endocytosis pathways. 
Though exocytosis is clearly important in the excretory canal, and every cell, the focus of 
this chapter will be on endocytosis.   
  Cells internalize material from the outside environment, along with lipids and 
proteins within the plasmid membrane, by endocytosis. Once endocytosed, material can 
travel onto different pathways. Material can continue through the typical, and well-
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characterized pathway, to the lysosome for degradation. Or material can be returned to the 
plasma membrane, through a less characterized pathway, the recycling pathway. Because 
the plasma membrane and the molecules located within it are constantly being turned 
over, both production and maintenance of these molecules that are being recycled need to 
be properly coordinated and efficient. In fact it is estimated that cells internalize the 
equivalent of their cell surface as many as five times an hour! (Grant and Donaldson, 
2009; Steinman et al., 1983) Things are even more complicated in polarized cells. In 
polarized cells material is take up from the two distinct surfaces, the apical and basal 
surfaces. For the return of material to these separate surfaces, things need to be regulated 
so it goes to the proper surface and the amount of material is correct and maintained 
(Maxfield and McGraw, 2004; Rodriguez-Boulan et al., 2005). 
  There are many regulators of both exocytic and endocytic pathways, particularly 
the family of Rab GTPases. As mentioned in chapter four, GTPases function by cycling 
between two different forms, the active, GTP bound form and the inactive, GDP bound 
form. These Rab proteins are distributed to distinct intracellular compartments and carry 
out different roles in transporting materials. There are many Rab proteins, making up the 
largest family of small GTPase proteins, of which humans have more than 60 (Zerial and 
McBride, 2001).  
  Material can be internalized through a clathrin-dependent or clathrin-independent 
manner (Pearse, 1976; van Deurs et al., 1993). Once internalized, material is passed to 
early endosomes. The early endosome is the site of cargo sorting; it is here the decision is 
made whether material will continue on to be degraded or will be recycled back to the 
plasma membrane. Early endosomes are identified by the presence of the GTPase RAB-5. 
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RAB-5 plays a role in regulation of both endosome motility and heterotypic and 
homotypic fusion of endocytic vesicles and early endosomes (Bucci et al., 1992; Gorvel et 
al., 1991; Zahraoui et al., 1989). Functional RAB-5 requires the presence of EEA-1 for 
endosome fusion. EEA-1 is a RAB-5 effector that contains a FYVE domain involved in 
binding to PI3P; this membrane binding allows EEA-1 to act a tether to assist in 
membrane fusion (Maxfield and McGraw, 2004; Mu et al., 1995; Simonsen et al., 1998) 
  If material continues through the pathway on its way to degradation it will stay 
within the early endosomes and this endosome will mature into a late endosome, by 
changing both shape and internal environment. A late endosome is characterized by both 
the shape and acidity, along with the presence of RAB-7. RAB-7 replaces RAB-5 as the 
GTPase, and membrane organizer, as the early endosome matures into the late endosome. 
This process is carried out by a Rab ‘conversion’ or ‘switch’ that involves RAB-5 
bringing in effectors that will ultimately result in the activation of RAB-7 (Del Conte-
Zerial et al., 2008; Rink et al., 2005). The material will then continue to the lysosome 
where it will be degraded.  
Molecules may also return to the plasma membrane, and can do this through two 
possible routes. Material can return to the plasma membrane directly, through a process 
that is called ‘rapid recycling’, or can recycle through the recycling endosome and then 
eventually back to the plasmid membrane through the process termed ‘slow recycling’ 
(Maxfield and McGraw, 2004). The mechanisms and steps of these two pathways are less 
characterized than the degradation pathway.  
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Rapid recycling returns material to the plasma membrane directly from the early 
endosomes, is known to involve RAB-4 and RAB-35 for this process (Grant and 
Donaldson, 2009). 
If material is recycled and goes through the ‘slow recycling’ pathway, material 
will be passed from the early endosome to the common recycling endosome (CE), also 
known as the subapical compartment (SAC), which is enriched with Rab-11 (Hoekstra et 
al., 2004; Ullrich et al., 1996). This common recycling endosome is where material 
received from both apical early endosomes (AEE) and basal early endosomes (BEE) will 
merge. In C. elegans, RME-1 (Receptor Mediated Endocytosis-1) is needed for trafficking 
of material from the recycling endosome back to the plasma membrane; it has also been 
shown for trafficking to the golgi (Grant et al., 2001; Grant and Caplan, 2008; Lin et al., 
2001).  
Though RABs are the main drivers behind trafficking within a cell, they require 
the assistance of many effectors to carry out their roles (Grosshans et al., 2006). These 
effectors assist in different processes of trafficking with RABs, including vesicle budding, 
vesicle delivery, tethering and fusion of the vesicles. Because RABs bind directly to the 
membrane of their corresponding compartments, many of these effectors localize there as 
well. These localized effectors may assist in the formation and bending of membranes for 
proper trafficking (Jean and Kiger, 2012) 
  Because many members of the IRGP family have shown localization with 
intracellular membranes and structural proteins (Kaiser et al., 2004; Petkova et al., 2012; 
Singh et al., 2006) it was thought that maybe EXC-1 is playing a similar role within the 
canal.  
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 Within the Buechner lab we have a group of markers that label certain subcellular 
components; these markers were made by former graduate student Brendan Mattingly 
(Mattingly and Buechner, 2011). All of the markers are under the control of exc-9 
promoter. This promoter was chosen because the sequence and regions are well 
characterized and shows moderate levels of expression within the canal (Tong and 
Buechner, 2008). Because exc-9 is also expressed within other tissues within the worm the 
markers do show up in other tissues including the uterine seam cell and in some head 
neurons. However, none of these tissues lay over the canal obstructing vision of the canal 
when doing microscope work. Under the control of the promoter is an N-terminal 
mCherry marker that will have the marker of interest in frame with the mCherry. All of 
these markers were integrated with the help of undergraduate, Elinor Brown. There are 
nine different markers, Figure 7.2a labeling different compartments and molecules within 
the canal, Table 7.2a 
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Subcellular Marker Subcellular Compartment 
Clathrin Heavy coat (CHC-1) Clathrin Heavy Coat 
RAB-5 Endocytic vesicles and Early Endosomes 
EEA-1 Early Endosomes 
RAB-7 Late Endosomes 
RAB-11 Recycling Endosomes 
RME-1  Recycling Endosomes 
GLO-1 Lysosomes 
GRIP Golgi 
Cdc42 GTPase Cdc42 
Table 7.2a Subcellular markers and their corresponding compartments. 
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Figure 7.2a Subcellular Markers 
Diagram of view inside the excretory canal with the subcellular compartments indicated 
in gray and their corresponding markers indicated in red. 
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7.3 Subcellular localization of EXC-1 
To get a better idea of what EXC-1 might be doing in the cell, studies were 
carried out to determine the subcellular location of EXC-1. Many attempts were carried 
out to make a translational reporter of EXC-1, containing its native promoter and 
genomic sequence in-frame with fluorescent marker GFP. Unfortunately, because of the 
size of exc-1 transcript, 6.6kb, it was very difficult to try and place it into a vector. So for 
localization of EXC-1 with in the canal I have used a construct that is under the control of 
a canal-specific promoter, vha-1 (plasmid, pBK109). When injected into exc-1 (rh26) 
worms, it rescues and shows localization throughout the canal, but is richer towards the 
apical lumen Figure 7.3a. This enrichment near the apical surface is also found with 
EXC-5 and EXC-9 (Suzuki et al., 2001; Tong and Buechner, 2008).  
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Figure 7.3a EXC-1 localization 
A construct expressing EXC-1 cDNA under the control of canal-specific promoter, vha-1, 
was expressed throughout the cytoplasm of the canals with strong apical localization. 
Scale bar, 10µm.  
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7.4 Subcellular markers 
When looking at these markers in wild-type worms (N2 – that have been more 
than 5 times outcrossed from integration) most of them showed punctate distribution, 
Figure 7.4a and 7.4b. CDC42 showed relatively even expression throughout the cytoplasm 
of the canal, Figure 7.4a.  
Because of these marker strains have been integrated into the DNA, I was able to 
cross them into my exc-1 (rh26) mutant worms, relatively easy. Analyses of these 
subcellular markers were carried out on L4 or young adult hermaphrodites. When 
compared to wild-type worms, many of the markers looked very similar with their 
distribution, including: CHC-1, RAB-7, GLO-1, GRIP, RAB-11 and CDC42, Figure 
7.4a. However, EEA-1 and RME-1 showed extreme variation in distribution when 
compared to wild type, Figure 7.4b and 7.4c. EEA-1 (Early Endosome Antigen 1) labels 
endocytic vesicles and RME-1 (Receptor-Mediated Endocytosis) labels recycling 
endosomes.  EEA-1 shows accumulation, but only in cystic regions. Vesicles seemed to 
be relatively normal in regions where the canal was of normal diameter but a high 
amount found around the cysts. RME-1 showed the opposite effect from EEA-1. RME-1 
was located normally in regions where the canal was of wild-type width but there was a 
loss of the RME-1 marker around the cysts. This phenotype of a build-up of EEA-1 and 
depletion of RME-1 around cystic regions was also found in exc-5 (rh232) mutants by 
Brendan Mattingly. This suggests that EXC-1 and EXC-5 may be working in the same 
region within the canal and seem to be working between trafficking of early endosomes 
to recycling endosomes, with EXC-1 most likely working upstream of EXC-5.  
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Figure 7.4a  Most subcellular markers show no major effects in exc-1 animals. 
Fluorescence of animals expressing stable integrated arrays of fluorescently labeled 
subcellular markers within the excretory canals, driven by moderate expression marker 
Pexc-9.  (A,B) mCherry::cdc-42 primarily labels cytoplasm; (C,D) mCherry::chc-1, 
clathrin-coated pits; (E,F) mCherry::rab-5, early endosomes; (G,H) mCherry::rab-7, late 
endosomes; (I,J) mCherry::glo-1, lysosomes; (K,L) mCherry::GRIP, Golgi.  Panels 
(A,C,E,G,I,K) show expression in a wild-type background; panels (B,D,F,H,J,L) show 
expression in exc-1(rh26) background.  Arrows indicate position of large cysts in exc-1 
mutants.  All bars 10 $m. Fluorescence brightened in all figures to show puncta.  
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Figure 7.4b exc-1 shows accumulation of EEA-1 and loss of RME-1 in cystic regions.  
Fluorescence of animals expressing stable integrated arrays of fluorescently labeled 
subcellular markers within the excretory canals, driven by moderate expression marker 
Pexc-9.  (A,B) show distribution of EEA-1; (C,D) show distribution of RME-1. Puncta is 
evenly distributed in wild-type worms (A, C) but EEA-1 is built (B) and RME-1 is lost 
(D) up in cystic regions of exc-1 mutants. Scale bar, 10µm. 
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Figure 7.4c.  Cysts accumulate EEA-1 while losing RME-1 expression 
(A,C) Canals expressing integrated array of Pexc-9::mCherry::eea-1 to mark early 
endosomes.  (B,D)  Canals expressing integrated array of Pexc-9::mCherry::eea-1 to 
mark recycling endosomes.  Animal in (B) additionally carries Pvha-1::gfp to label entire 
canal cytoplasm.  (A,B) exc-1(rh26) mutants.  (C,D) control expression in otherwise 
wild-type animals.  Arrowheads in all panels show diameter of normal-width canal.  
Arrows in (A) and (B) indicates cyst at posterior terminus of canal.  Arrows in (C) and 
(D) indicate typical punctate appearance of endosomes.  Bars:  10 $m.  All figures are 
brightened to show position of puncta in normal-width canals. 
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7.5 Electron Micrograph Images 
Matthew Buechner carried out the electron micrograph imaging in Dave Hall’s 
lab many years ago (Center for C. elegans Anatomy, Dept. of Neuroscience, Albert 
Einstein College of Medicine, Bronx, NY, 10461), Figure 7.5a, see Figure 1.5c for 
comparison to wild-type. 
 In an area of a mutant canal where cysts are forming, Figure 7.5a, canaliculi 
appear disordered, though the number of vesicles seems normal.  Diameter of canaliculi 
is less uniform than in wild-type animals, and the thick electron-dense material that 
normally surrounds the lumen is disrupted, with cystic areas lacking the material, which 
appears in a disorganized manner in the cytoplasm, as previously noticed in other exc 
mutants(Fujita et al., 2003; Kolotuev et al., 2013; Suzuki et al., 2001).  Finally, there are 
many vesicles of various sizes among and surrounding the canaliculi, which could reflect 
difficulties in forming the canaliculi, or an overabundance of endosomal compartments, 
possibly a build up of early endosomes, like we see with the subcellular markers.  
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Figure 7.5a.  Electron micrograph of exc-1(rh26) excretory canal.    
Excretory cell body of L4 animal developing cysts.  Nuc, cell nucleus. Lu, lumen of 
canal, surrounded by many canalicular vesicles.  E, possible endosomes or abnormally 
large vesicles both outside and within area of canaliculi.  Arrows show electron-dense 
terminal web-like material, both partially surrounding lumen, and disorganized material 
not adjacent to lumen.  Arrowheads indicate regions of lumen lacking electron-dense 
material. 
 
 
 
 
 
! $&'!
7.6 Summary 
With the use of subcellular markers, it was found that exc-1 mutant worms, 
around cystic regions, exhibit a build-up of early endosome marker, EEA-1 and a loss of 
recycling endosomes, indicated by marker RME-1. EM images suggest build up of 
endosomal compartments as well. These phenotypes suggest that EXC-1 is necessary for 
proper trafficking between these two compartments. This subcellular marker phenotype 
was also observed in exc-5 worms, suggesting they may work together, with EXC-1 
working upstream of EXC-5 (suggested from genetic interactions, Chapter 5).  
There are many questions that arise from these results. How do EXC proteins 
facilitate movement of material from early to recycling endosomes? EXC proteins could 
facilitate pinching off of small vesicles from early endosomes, but it is also possible that 
EXC proteins could regulate motility of vesicles that pinch off normally. Is EXC-1 
playing a similar role in membrane bending that IRGP might be playing? Previous work 
suggests that IRGP might be involved with molecules that bend membranes (Gregoire et 
al., 2011; Petkova et al., 2012), maybe EXC-1 is doing something similar within the 
excretory canal. These are questions that would need to be addressed with further studies.  
 
 
7.7 Materials and Methods 
Localization of EXC-1 
 The construct for localization of EXC-1 used the vector containing the promoter 
vha-1 (pCV01) with the coding region of GFP. cDNA corresponding to EXC-1 was 
isolated the same way as described in Chapter 2. PCR amplification of this cDNA was 
carried out with primers 5’GTCGACTCTAGAGATGGGACACAAAA and 5’ 
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ATAATTACCGGTCCATGAACTCCGGC that contained cut sites, XbaI and AgeI 
respectively, to allow for insertion into the plasmid pCV01. This construct was injected at 
a concentration of 25ng/µl and canals of F1 progeny of injected worms were scored in 
same fashion as described in chapter 2.  
 
Subcellular Markers 
 All of the subcellular markers were designed, constructed, and integrated into the 
genome of N2 worms as previously described (Mattingly and Buechner, 2011).  Strains 
carrying the different integrated subcellular markers were crossed to exc-1 (rh26) worms.  
F2 progeny expressing both the mutant phenotype and the fluorescent marker were 
isolated and maintained as a homozygous strain of both the subcellular marker and exc-1 
(rh26). Only two of the marker strains, EEA-1 and RME-1 required a recombination 
event to occurs, as they are located on the X chromosome as well.  
 
Confocal Images 
Live worms were mounted on 2% agarose pads with added 10mM muscimol or 
0.5% 1-phenoxy-2-propanol as an anesthetic, as described previously (Sulston and 
Hodgkin, 1988).  Confocal images were taken on an FV1000 Confocal microscope 
(Olympus) laser scanning confocal microscope, with lasers set to 488 nm excitation 
(GFP) or 543 nm excitation and (mCherry).  Images were captured via FluoView optics, 
and analyzed with ImageJ software. 
 
 
! $&)!
Subcellular Marker Measurements 
NIH program ImageJ was used to analyze the brightness and locations of the 
subcellular markers in cystic and non-cystic areas of the excretory canals.  Worms 
selected for analysis did not have medium or large multiple cysts grouped together, and 
had both a region of non-cystic, normal canal diameter and a cystic region that was 
usually located at the ends of the tubules.  A segmented line was created along the length 
of the tubule with width wide enough to cover the largest cysts.  A plot profile was 
recorded for this segmented line; from each value was subtracted the average value of a 
plot profile for a dark background outside the worm in that micrograph. To normalize the 
values a region of noncystic, normal-looking canal was assigned a brightness level of 
100.   
 
Electron Micrograph 
  Matthew Buechner carried out the electron micrograph imagining in Dave Hall’s 
lab (Center for C. elegans Anatomy, Dept. of Neuroscience, Albert Einstein College of 
Medicine, Bronx, NY, 10461) For electron microscopy, L4 larvae and young adults were 
cut in midbody and fixed immediately in buffered (100 mM Hepes, pH 7.5) 3% 
glutaraldehyde, followed by post-fixation in buffered 1% OsO4 (Hall, 1995; Sulston and 
Hodgkin, 1988).  After encasement in 1% agar, samples were dehydrated and embedded 
in Polybed 812 resin (Polysciences).  Serial sections, ca. 70 nm, were post-stained in 
uranyl acetate followed by lead citrate. 
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8.1 Abstract 
  In both exc-1 and exc-5 mutants there is a disruption in the recycling pathway 
exhibited by a build up of EEA-1 and a loss of RME-1, within the excretory canal. 
Confocal imaging was used to get a closer look at the trafficking within the excretory 
canal. This section describes the foundation work for watching vesicles move and carrying 
out FRAP studies, techniques that will be continued in the Buechner lab 
 
8.2 Introduction 
Within exc-1 and exc-5 mutants there is a disruption within the trafficking 
pathway within the excretory canal. Around cystic regions there is a build-up of EEA-1 
and loss of RME-1. Many questions arise in regards to this phenotype: 1. Is the build-up 
of EEA-1 one large vesicle or is it an accumulation of many vesicles? 2. Is the build up of 
EEA-1, or loss of RME-1 due to the disruptions in the movement of vesicles? 3. Is 
vesicular trafficking faster or slower in exc-1 and exc-5 mutants compared to wild type? 4. 
Do the vesicles only move in one direction, are they only able to move in an anterorgrade 
direction or a posteriorgrade direction? To address these questions we wanted to 
investigate things closer on the subcellular level and watch the movement of vesicles 
within the canal.  
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To watch vesicles move we set out to do confocal imaging and Fluorescence 
Recovery After Photobleaching (FRAP) studies. FRAP assays allow for analysis of 
protein movement within a cell or located within the cell membrane (Axelrod et al., 1976; 
Goehring et al., 2010). As stated in the previous chapter, all of our subcellular markers are 
labeled with a mCherry flourophore 594 nm emission with a laser we are able to 
photobleach the mCherry marker within the canal and observe its recovery. To carry out 
these studies I had the assistance of Brian Ackley with use of his confocal microscope.  
 
8.3 Results 
I focused on a couple of the subcellular markers for these studies; RAB-5, RAB-7 
and RME-1. I chose these markers for a couple of reasons: first, RAB-5 and RME-1 are 
both markers that seem to show disruption within exc-1 mutants, an extreme phenotype 
for RME-1 and a milder phenotype for RAB-5. RAB-7 was chosen to serve as a control, 
because of similar puncta localization in both wild-type and exc-1 mutant worms. EEA-1 
was not chosen for these pilot experiments for a couple of reasons, first the marker is 
faintly expressed, making it very hard for analyzing the puncta, especially in non-cystic 
regions. Second, the EEA-1 marker tends to photobleach quickly, not allowing for enough 
time for accurate FRAP studies.   
While observing these markers within the excretory canal, it was really interesting 
and exciting to see how the subcellular markers move and the timing of their movement 
All of the subcellular markers studied were able to move in both anterograde and 
posteriorgrade directions. With Image J, kymographs were made, showing the movement 
in both directions and giving an estimate of movement rates, Figure 8.3a.  
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Also identifiable with the confocal microscope was all the different shapes of 
endosomes (RAB-5 – Early Endosomes, RAB-7 – Late Endosomes, and RME-1 – 
Recycling endosomes). Fellow graduate student, Hikmat Al-Hashmi, is continuing with 
these FRAP studies and is developing a way for measurement of both endosome size and 
movement. It will be exciting to see the differences between wild-type and various exc 
mutants.   
Next to carry out FRAP we wanted to be able to bleach different areas within the 
canal and determine its half-life and time of recovery.  I was successful in being able to 
bleach the subcellular markers within the canal and measured fluorescence recovery 
caused by influx of vesicles into the area, Figure 8.3c. The half-time of recovery for early 
endosomes (marked with RAB-5::mCherry) in an L4 worm, was 34 seconds for a 
bleached area of about 8mm in length. Recovery of untethered proteins (cytoplasmic GFP) 
was very rapid, and we were unable to acquire any visible dimming of this marker with 
sustained bleaching.  
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Figure 8.3a Vesicles move in both anterograde and posteriorgrade directions. 
 Early endosomes move in both anteriorgrade (indicated by arrows in left column) 
and posteriorgrade (indicated by arrows in right column) directions. Worms carry the 
integrated transgene, Pexc-9::mCherry::RAB-5.  
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Figure 8.3b Kymograph 
 
Yellow line in the right panel indicates area that was used for Kymograph. White 
areas on kymograph indicate early endosome vesicles and arrows indicate movement 
during the 54 seconds of imaging. Worms carry the integrated transgene, Pexc-
9::mCherry::RAB-5.  
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Figure 8.3c FRAP 
 Area that has been photobleached is able to recover. (A) Image of a left canal 
from a worm with integrated transgene Pexc-9::mCherry::RAB-5 before Photobleaching. 
(B) Loss of puncta indicate successful bleaching of area in the canal. (C) Graph shows 
fluorescence before bleaching and its recovery indicated by relative fluorescence.  
 
8.4 Summary 
 With the use of a laser confocal microscope, we are able to carry out FRAP 
studies to get a closer look at what is going on within the excretory canal. At this time 
studies were not carried out to observe possible differences between the cystic and non-
cystic regions, but this work will be continued in the lab and we now have the 
understanding and tools to do it. 
 
8.5 Materials and Methods 
FRAP assays were carried out on a FV1000 Confocal microscope (Olympus) 
laser scanning confocal microscope, with lasers set to 488 nm excitation (GFP) or 546 
nm (mCherry).  Images were captured via FluoView optics, and analyzed with ImageJ 
software. Photobleach of subcellular markers were with a laser at 594 emission.  
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A plot profile was recorded for the area what was photobleached; from each value 
was subtracted the average value of a plot profile for a dark background outside the worm 
in that micrograph. 100% Fluorescence intensity was assigned to the brightness level of 
area that was bleached before FRAP studies were carried out.  
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Chapter 9 
Discussion 
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9.1 Discussion 
 
exc-1 mutants have a varied cystic phenotype  
  In C. elegans, exc-1 mutants were identified by its severe deficiencies in 
maintenance of the narrow lumen of the excretory canals. exc-1 mutants show a varied 
phenotype; from worms that have canals that almost look wild-type  with canals extending 
most of the length with a small cyst, to a serve cystic phenotype with short canals 
containing many large cysts. Through the use of rescue assays and RNAi, I was able to 
map and identify the exc-1 gene. Knockdown of the predicted gene C46E1.3 phenocopies 
exc-1, and injection of this clone into exc-1 mutant worms rescues the cystic phenotype. 
We conclude that clone C46E1.3 encodes the exc-1 gene. 
  
exc-1 is expressed in the amphid sheath 
 EXC-1 is expressed in the excretory canal, and the glial amphid sheath cells. exc-
1 (rh26) mutants exhibit occasional, abnormal formation of cyst-like structures or large 
vacuoles along the axon-like process. These cyst-like structures or large vacuoles do not 
seem to disrupt the worm’s ability to form the amphid channel properly and take up dye 
from the outside environment. Also, exc-1 mutants do not display any behavioral defects 
that may suggest that the amphid neurons aren’t able to pass through the amphid sheath 
similar to wild-type. Though exc-1 is not required to form and maintain the tubule-like 
portion of the amphid channel it may be carrying out a similar role on the cellular level as 
within the canal.    
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Interestingly, the pros-1 (ceh-26) transcription factor, encoding the C. elegans 
homologue to the prospero homeobox gene, is also expressed primarily in the excretory 
canal and amphid sheath cells (Kolotuev et al., 2013).  And is required for proper tubule 
formation as a loss of function results in a cystic phenotype as well. In this study, the 
amphid sheath structure was not characterized in mutants so it is unknown if pros-1 
mutants exhibit structural defects in the amphid sheath as well. A study of genes whose 
transcription is regulated by Prospero or CEH-26 (PROS-1) included exc-5 but not exc-1, 
which suggests that both exc-1 and pros-1 transcription may be activated together by a 
common upstream factor.   
 
exc-1 encodes a IRGP 
  EXC-1 shows strongest homology to a large family of Immunity-Related GTPase 
that are represented in many species. These proteins were discovered in mice, but are 
deleted in many mammals. Two members of the IRGP family are found in humans, IRGM 
and IRGC. EXC-1 shows strongest homology to IRGC, which is not inducible by 
interferons in any organism studied. A common feature of these proteins is an incomplete 
Ras-related GTP-binding domain that contains the core G1 – G4 subdomain sequences 
regulating binding to GTP and to activity regulators, guanine exchange factors (GEF) and 
guanine activating protein (GAP), but with weaker homology to the Ras G5 subdomain, 
though this region shows weak homology throughout the RAS superfamily. EXC-1 also 
shows strong structural homology to the IRGP GTP binding domain, particularly at the 
nucleotide binding surface. IRGC and IRGM proteins contain homodimerization motifs in 
the center of the RAS homology domain. This region appears to be missing in EXC-1; this 
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may be because EXC-1 already contains two RAS homology domains within one protein. 
This feature of two RAS homology domains found in EXC-1 adds to the complexity of 
the protein within the cell. With tandem Ras homology domains within the protein this 
may remove a step in binding and dimerizing for function.  
  Though the two Ras homology domains lack the G5 motif, EXC-1 does seem to 
function as a true GTPase. When EXC-1 is in its wild-type state and the genomic 
sequence has not been altered, it is able to rescue the exc-1 cystic phenotype and even 
cause an overexpressed, convoluted canal phenotype. When EXC-1 is in a constitutively 
active form, it is able to rescue the cystic phenotype; however it does not induce a 
convoluted canal structure, suggesting that EXC-1 may require the ability to cycle 
between active and inactive forms to function properly. Another suggestion that the EXC-
1 Ras homology domain is functional, is its variable binding partners, that depend on 
GTP/GDP binding.  
 
exc-1 interacts with exc-5 and exc-9 
 
 Epistasis studies carried out in the lab have identified a genetic pathway required 
for tubule structure, this pathway is EXC-9 ! EXC-1 ! EXC-5, EXC-9 acts upstream of 
both EXC-1 and EXC-5 and EXC-1 acts upstream of EXC-5. Yeast two-hybrid studies 
indicate that EXC-1 and EXC-9 bind to each other but only when EXC-1 is in its wild-
type or constitutively active state, as the dominant-negative form is unable to interact 
with EXC-9. EXC-9 was found to bind to the region including the N-terminus, proline-
rich region, and the first Ras homology domain. This may suggest that EXC-1 may 
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undergo a conformational change when in its inactive, GDP bound form, such that the 
proline rich region and 1st Ras homology domains are not exposed to interact with EXC-
9. Further studies are required to verify this possibility. Other proteins that may serve as 
binding partners, possibly to the 2nd Ras homology domain, remain to be discovered as 
well. All together, these results suggest that EXC-1 binds to EXC-9 only in certain 
conditions and this binding is responsible for downstream activation of EXC-5 to 
maintain tubule shape.  
  Though EXC-1, EXC-9 and EXC-5 are shown to interact, it seems that this 
pathway requirement only occurs within the excretory canal. EXC-1, EXC-9 and EXC-5 
all show separate and non-overlapping expression outside of the excretory canal.  EXC-1 
is expressed in the amphid sheath; EXC-9 within many neurons and is highly expressed in 
the uterine seam cell; the close EXC-9 homologue VALV-1 within multiple valves in the 
digestive and reproductive tracts (Tong and Buechner, 2008); and EXC-5 is highly 
expressed in the pharyngeal muscles (Suzuki et al., 2001).  This also indicates that EXC-1 
has different binding partners within the amphid sheath and possible function because of 
this. 
 
EXC-1 and EXC-5 are needed for proper recycling 
  
 exc-1 loss-of-function mutants exhibit defects within the intracellular 
trafficking of the excretory canal. When EXC-1 is not present within the canal there is a 
build-up of the early endosome marker, EEA-1, and consequently a loss of recycling 
endosome marker, RME-1. This is also seen in exc-5 loss-of-function mutants. EXC-1 and 
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EXC-5 seem to be required for the proper trafficking of material from the early endosome 
to the recycling endosome, and when this function is lost there is weakening at the apical 
surface, Figure 9.1a and 9.1b. The pressure from the canal pushes on these weak spots and 
results in a cyst formation. It is likely that future studies will show that EXC-9 is required 
in this pathway as well.    
  The excretory canal needs to maintain a proper balance of material being 
transported to the apical surface to maintain the lumenal shape. This is also important for 
the basal surface, when you have too much of EXC-1 or EXC-5 there seems to be a loss of 
transport of material to the basal surface, resulting in not enough material to extend out. 
The canal is not able to extend and stays at the cell body, though the apical surface is 
maintained it results in convoluting on itself. Both are disrupted suggesting that EXC-1 
and EXC-5 play a role between the two and required a proper balance of material be 
transported from the common endosome to both the apical and basal surfaces.  
Genetic results suggest that EXC-9 and EXC-1 both act upstream of the guanine 
exchange factor EXC-5, which mediates disappearance or movement of early endosomes 
and appearance of labeled recycling endosomes to prevent cyst formation.  Our results did 
not find direct binding of EXC-1 to EXC-5, which suggests that EXC-1 activates some 
other protein that causes activated EXC-5 to mediate endosomal conversion to maintain 
narrow tubular structure. 
 
EXC-1 as a model for IRG 
The function of IRG proteins is becoming better understood.  Most are stimulated 
through actions of the immune system.  The human IRGM protein is believed to function 
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to regulate cell autophagy.  The IRGC protein is the most widely distributed IRG protein, 
with a homologue in many mammalian species, and is not activated through activity of the 
immune system.  In C. elegans exc-1 mutants, the early and recycling endosomes are 
strongly affected, while only minor effects on late endosome levels were detected; these 
observations suggest that autophagy is not at issue here.  We conclude that the EXC-1 
protein, and by inference other IRGC proteins, act at a different step of endosomal 
trafficking than does human IRGM protein.  Mice have many of these proteins, and so 
could regulate endosome formation at many trafficking steps. 
  Our yeast 2-hybrid show that activated EXC-1 binds directly to EXC-9 protein.  
EXC-9 is a member of the CRIP (Cysteine-Rich Intestinal Proteins) family of small 
cytoplasmic LIM-domain protein-binding proteins, which are expressed particularly 
highly in the mammalian intestine, but are found in many tissues.  Our genetic results 
have shown that EXC-9 acts upstream of EXC-1 to maintain narrow tubular structure, and 
provide a possible model for investigating the function of CRIP as a possible binding 
partner acting upstream of mammalian IRG proteins. 
 
The excretory canal now 
 From these studies we have tied in the roles of EXC-1, EXC-9 and EXC-5 as 
proteins all required to maintain the lumenal shape within the excretory canal, with EXC-
1 and EXC-9 binding and somehow activating the function of EXC-5 to recycle material 
at the apical surface by trafficking material from the early endosome to the recycling 
endosome, see models 9.1 a, b and c. 
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Further studies of interactions of EXC proteins with potential partners involved in 
endosome movement and formation, cytoskeletal structure, and canalicular vesicle 
structure, should delineate the roles of these proteins in maintenance of narrow tubular 
structure as well as functions in other cell types in nematodes and mammals. 
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Figure 9.1a EXC-1 within the canal 
EXC-1 functions in the canal by binding to EXC-9 in its wild-type or active form, which 
is needed for indirect, upstream activation of EXC-5. Together, EXC-1, EXC-5 and 
EXC-9 work together for the proper trafficking of material from the early endosome to 
the recycling endosome for maintenance of the apical surface.  
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Figure 9.1b Loss of exc-1.  
 When EXC-1 is missing, or in its GDP-bound form, EXC-1 is no longer able to 
bind with EXC-9 resulting in a loss of downstream activation of EXC-5. Without the 
proper function of EXC-1 (or EXC-5 and EXC-9) material is unable to be transported 
from the early endosome to the recycling endosome and back to the apical/lumenal 
surface. This loss of material at the apical surface results in a weakened surface.  The 
pressure within the lumen of the canal pushes on this weakened surface and results in 
cyst formation.  
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Figure 9.1c Model of canal at the end of my studies. 
Since I have joined the lab, EXC-1, EXC-5 and EXC-9 have been shown to interact 
together for proper trafficking within the canal. Intermediate filament protein, IFB-1, has 
been identified for proper tubule shape as well (Kolotuev et al., 2013). EXC-2 may be 
another intermediate filament subunit as well, possible interacting with IFB-1 (remains to 
be verified). EXC-6 has been identified as a formin, which is also involved with 
cytoskeletal proteins. And Aquaporin 8 (AQP-8) has been identified for proper tubule 
formation. EXC-3 remains to be identified. Compare to model at the beginning of my 
studies, Figure 1.6. 
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